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ABSTRACT
Mathematical modeling in understanding NFкB signaling pathway
Huanling Liu
Chronic diseases, cancers and diabetes are associated with dysregulation of many
biochemical cues. These biochemical cues are proteins that regulate cellular activity
migration and death. The synthesis of these proteins is regulated by nuclear transcription
factors. One of the most studied transcription factor is nuclear factor kappa B (NFкB).
Many different proteins have been identified that regulate the activity of NFкB. Yet, how
these proteins regulate NFкB is still unclear.
Understanding the regulation of NFкB is important for developing drugs to treat these
diseases. Our long term goal is to understand the mechanisms that regulate NFкB activity.
The goal of this research is to identify how NFкB activity is regulated. As a model
system, we will use LPS to stimulate macrophage cells with or without 3, 4dichloropropionanilide (DCPA) treatment. DCPA is a post-emergent herbicide used for
controlling weeds in rice crops. Exposure to DCPA causes increases in liver and spleen
weight demonstrated by toxicity study on rats. Previous study in our lab showed that
DCPA could modulate NFкB activity. Our central hypothesis is that a mathematical
model can be used to infer the regulation steps that are altered following DCPA treatment.
To test our central hypothesis, we performed the following specific aim:
Establish that NFкB is differentially regulated by IкBα and IкBβ and that these proteins
are in turn differentially regulated by DCPA. Moreover, a mathematical model was used
to establish observed dynamics of NFкB activities. Our working hypothesis is that an
ordinary differential equation (ODE)-based model that includes NFкB regulation by IкBα
proteins can capture the observed dynamics. Furthermore, we used an empirical Bayesian
approach to establish confidence in model parameters. Then, we included IкBβ in the
model to more realistically describe the regulation of NFкB activity in macrophages.
We expect that the results of this research will lead to greater understanding of the
regulatory mechanism of NFкB signaling pathway in macrophages and have important
implication for human health. This improved understanding may also inspire new ideas to
treat these diseases.
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CHAPTER 1
LITERATURE REVIEW
1.1 Nuclear factor kappa B
Chronic diseases, cancers and diabetes are associated with dysregulation of many
biochemical cues [1, 2]. These biochemical cues are proteins that regulate cellular
activity migration and death. The synthesis of these proteins is regulated by nuclear
transcription factors. One of the most studied transcription factors is nuclear factor kappa
B (NFкB), which plays an important role in regulating the expression of various
inflammatory mediators [3,4,5]. Inflammatory mediators are released by immune cells
during times when harmful agents invade our body. Immune cells like macrophages can
recognize the bacterial cell wall components, such as lipopolysaccharide (LPS), and
secret inflammatory mediators like TNFα and IL-1. In rheumatoid arthritis patients,
inflammatory mediators like TNFα and IL-1 are secreted by primarily macrophages and
also upregulated by NFкB. Then TNFα and IL-1 activate NFкB in a wide variety of cells
to produce more inflammatory mediators inducing cytokines [41]. Roy L and co-workers
[42] observed that pro-arthritic mice had significant increase in breast cancer-associated
secondary metastasis compared to non-arthritic mice. Increased inflammatory mediators
like IL-6, TNFα and IL-17 were measured on arthritic mice and were suggested as the
underlying factors that are responsible for the increased metastasis in the arthritic mice.
NFкB was also observed constitutively active in mononuclear cells from patients with
type 1 diabetes and some cancers [1, 4]. For inflammation-associated cancers, activity of
NFкB was proposed to enhance tumor development by promoting inflammation.
Therefore, understanding the regulatory mechanisms for NFкB activity is important for
treating these diseases [6].
3,4-dichloropropionanilide (DCPA), which is also known as propanil, is a common
herbicide for control of weeds on commercial rice crops worldwide. DCPA has been
demonstrated suppressing inflammatory mediator TNFα production by macrophage
following the LPS stimulation on both mRNA and protein levels [27]. Further study on
1

the mechanism of DCPA suppressing macrophage functions by Frost and coworkers [29]
demonstrated that DCPA treatment decreases NFкB nuclear localization and DNA
binding in IC-21 cells following 10 g/ml LPS stimulation. A simple mathematical
model was built to display the effect of DCPA on NFкB activity [28]. DCPA treatment
resulted in a potentiation of early LPS-induced NFкB activation and could be a tool to
probe the fundamental aspects of NFкB signaling. However, the mechanism of DCPA
modulating NFкB is still not clear. Our current research aims to expand this model to
incorporate mechanisms by which NFкB is regulated in macrophages. Furthermore, an
empirical Bayesian approach will be used to establish confidence in model parameters
and the special aspects affected by DCPA treatment.
1.2 Regulation of NFкB activity
Many different proteins have been identified having ability to regulate NFкB activity.
Besides those proteins in the signaling process indentified as inhibitors of NFкB, a lot of
other compounds like small molecules are found to modulate NFкB activity [25,26,29].
DCPA has also been shown to alter NFкB activity [28]. Yet, how these proteins and
compounds regulate NFкB is still unclear [7, 8]. Moreover, the regulatory mechanisms
may be different in different cell types. In Figure 1 which is summarized Klinke [28], we
can see that NFкB is activated more rapidly in macrophages than in Fibroblasts following
LPS stimulations.[28] The different dynamics of NFкB activity may be caused by
different signaling pathways. Different cells have different functions in the immune
system. Macrophages are important and essential to the regulation of immune response
and the development of inflammation. Therefore, it is meaningful to Figure out the
mechanism of NFкB activity in macrophages.
IкB proteins is a family of similar proteins, including IкBα, IкBβ and IкBε that has been
identified as major inhibitors of NFкB activity in different kinds of cells [5,7]. IкBα,
IкBβ and IкBε proteins have several structural motifs in common, including six ankyrin
repeats and N-terminal regulatory regions (shown as Figure 2). The similarity in structure
also correlates to similar functions: they bind to NFкB, and mask the nuclear localization
sequence (NLS) of NFкB. In addition, phosphorylation of IкB proteins by IкB kinase
2

(IKK) liberates NFкB [9]. The slight differences in structure lead to differential functions
or mechanisms in regulating NFкB [10, 11, 34]. For instance, different dynamics of
NFкB activity in embryonic fibroblasts were observed in α-/-β-/- cells, α-/-ε-/- cells, and
β-/-ε-/- cells [11]. Mathematical models have been used to explain the discrete functions
of IкBα, IкBβ and IкBε proteins in regulation NFкB via negative feedbacks. IкBα
proteins are rapidly synthesized in response to NFкB and are suggested to provide strong
negative feedback leading to oscillations in NFкB activity. In contrast, IкBβ and IкBε
proteins dampen the long-term oscillatory activity of NFкB. Sparked by this work,
several other models has been built to help understanding the mechanism of different
proteins regulating NFкB activity following extracellular stimulations as reviewed in [12].

Figure 1 The dynamic activation of NF-κB in macrophages compared against
prior studies using fibroblasts. Nuclear NF-κB was assayed by EMSA at the
indicated times after persistent stimulation with 1 μg/ml LPS in macrophages (in
Klinke 2008, n = 8, values reported as average ± 95% confidence interval), 0.5
μg/ml LPS in fibroblasts demonstrated by Covert et al. (30) (○), and 0.1 μg/ml
LPS in fibroblasts demonstrated by Werner et al. (46) (×).
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Figure 2 The IκB family. Schematic diagram showing different IκB proteins that
contain several ankyrin repeats (ANK). Phosphorylation and ubiquitination at
specific amino acid residues are indicated. Proline (P), glutamic acid (E), serine
(S), and threonine (T) domains are indicated as PEST.
Besides IкBα, IкBβ and IкBε proteins, A20 is suggested as an important inhibitor of
NFкB activation by deactivating IKK [13] or by blocking the upstream activator of IKK
[14]. Prolonged NFкB activity was observed not only in A20-deficient fibroblasts
following TNF stimulation [15] but also in macrophages following LPS stimulation [16].
Persistent phosphorylation of IкBα proteins in A20-deficient cells following the
stimulation suggests that prolonged IKK activity results in persistent NFкB activity.
Although A20 is essential in regulating NFкB activity following extracellular stimuli, the
molecular mechanism of this regulation is still unknown. Ubiquitination (or
ubiquitylation) refers to the post-translational modification of a protein by the covalent
attachment (via an isopeptide bond) of one or more ubiquitin monomers. A20 has both
de-ubiquitination and ubiquitin ligase domains which label proteins for proteasomal
degradation. Wert and coworkers established receptor interacting protein (RIP) as an A20
substrate by analyzing possible ubiquitination in the TNF-induced NFкB signaling
pathway and found that A20 directly ubiquitinated RIP, which is essential for TNFinduced signaling [17].
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The expression of most of these important regulators of NFкB is also regulated by NFкB
activity [18]. For instance, NFкB directly promotes IкBα transcription [19]. NFкB
binding with IкBα results in a slower bound IкBα degradation rate compared to free IкBα
[20, 21], but increases phosphorylation of IкBα by IKK [22]. Thereby, NFкB is not only
responsible for the production but also stability of IкBα. For IкBβ and IкBε, less is
known about their regulation by NFкB. Kearns and coworkers studied the gene
expression of IкBα, IкBβ and IкBε in wild-type murine embryonic fibroblasts (MEFs)
and NFкB-deficient MEFs following TNF stimulation [23]. Gene expression of IкBα,
IкBβ and IкBε was observed increasing in wild-type cells following the stimulation, but
not in NFкB-deficient cells. Therefore, NFкB is essential for all of IкBα, IкBβ and IкBε
gene expression in MEFs following TNF stimulation. However, the dynamics of
expression in response to NFкB for these species are different. In particular, IкBβ and
IкBε had a 45 minutes transcription delay comparing to IкBα in wild-type MEFs
following TNF stimulation [23]. Although some intermediate transcription factors, like
Foxj1, which was demonstrated to have the ability to regulate IкBβ by Lin [24], may
cause the time delay, the mechanisms of these different promotions by NFкB are still
unknown. Similar to IкBα, rapid A20 gene expression was observed following NFкB
activation in wild-type MEFs and also in bone marrow-derived macrophages (BMDMs)
[15, 16]. NFкB controls gene expression of its inhibitors which forms auto-regulatory
feedback loops to terminate the NFкB response.
As illustrated by the regulation of A20 and IкBs on NFкB, these auto-feedback loops
play different roles in regulating NFкB dynamics. Given the reciprocal nature of
NFкB/IкB regulation, mathematical models integrated with biochemical studies have
been an instrumental tool to understand the regulation of NFкB [31]. Most of the models
focused on TNF-induced or LPS-induced NFкB activity in MEFs [13, 23, 30]. Biological
events were assembled into a biochemical reaction network and modeled using non-linear
ordinary differential equations. Parameters were refit to reproduce experimental data
under different conditions and assumptions [12], as shown in Figure 3. Figure 3-A
reproduced NFкB activity measured in wild-type MEFs following during persistent 6 h-
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long TNF stimulation, while Figure 3-C reproduced that after 15 min-long TNF
stimulation. Through this mathematical model which could reproduce some

[B] Schematic depiction

Figure 3 Schematic depiction of Lipniack’s model (B) and Model predictions
versus Hoffmann et al. (2002) measurements on wild-type cells (down) (A) NFkB during persistent 6 h-long TNF stimulation [13]; (C) NF-kB at and after 15
min-long TNF stimulation.
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experimental data measured under different conditions, the mechanism of NFкB
regulation by A20 and IкBα was proposed that A20 regulates NFкB activity through
inhibiting IKK activity while IкBα through binding with NFкB and keeping it in the
cytoplasm. Through mathematical modeling, the distinct function of other inhibitors in
controlling NFкB activity was also demonstrated [23, 32].
1.3 Mathematical modeling
Mathematical modeling has been demonstrated as an instrumental tool in understanding
signaling mechanisms in biological system [11-13]. Common modeling approaches give
the maximum likelihood estimate of some unknown parameters by comparing the
simulation results and experimental data[11,13, 45]. However, in biological systems, a
signaling network involves tens of or even hundreds of biological events like proteinprotein interaction, mRNA transcription and translation. Not all of these events are
currently measurable. Most of the time, only some of the parameters associated with
certain events can be measured. For other parameters, a slight change in value may not
influence the production or affect system results in ways that are difficult to separate
from other parameters. These parameters are called unidentifiable or inestimable. Like
experimental studies, we need to establish a level of confidence associate with how well
the mathematical model describes a system.
1.3.1 Values for Parameter Identification
Parameters associated with biological events can be measured directly by experiment or
estimated by analysis data using a mathematical method. For parameters that can’t be
measured currently, A priori identifiability approach was developed by Jacquez [52]. A
priori identifiability is used to check whether the values of the parameters at a point in
parameter space can be estimated independently for models described by systems of
ordinary differential equations. Klinke [28] used the approach to demonstrate that
estimates of the strength parameter of effect DCPA on NFкB activation could be
uniquely determined from the data. The sensitivity function is defined as
Sij(t) = (əyj(t)/əki) · ki/MAX(yj,(t))

(1)
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where yj represents model variables, ki denotes model parameters around a local optimum,
and the partial derivative values are scaled by the parameter value and the maximum
value of the model variable during the simulation. The sensitivity function is practically
approximated by obtaining the sensitivity measure Sij at a set of dicrete time points, tk,
and experimental conditions, [Cn]n. Then a reduced sensitivity matrix (M) is constructed
as
M = [Sij (t1, Cn0), ..., Sij (tk, Cn0),…, Sij (t1, Cnn), …, Sij (tk, Cnn)]T

(2)

A set of correlation coefficients between model parameters is calculated from M.
Parameters that are locally identifiable have correlations with all other parameters
between in practical -0.99 and +0.99. Parameters that are not locally identifiable, termed
a proiori unidentifiable, have correlations of greater than 0.95 and less than -0.95 with at
least one other parameter.
1.3.2 Simulated Annealing
Simulated Annealing (SA) is a random searching technique, developed in 1983 to deal
with highly nonlinear problems. The principle and advantages of SA was reviewed by
Busetti[56]. SA exploits an analogy between the way in which a metal cools and freezes
into a minimum energy crystalline structure (the annealing process) and the search for a
minimum in a more general system. The principle of SA approaching the global
maximization is similarly to using a bouncing ball which can bounce over mountains
from valley to valley. At the beginning, it starts from a “high temperature” bounce with
high energy to access any valley, and then finally get into a small range of valleys. The
SA method needs a generating distribution that generates possible valleys or states to be
explored and an acceptance distribution which depends on the difference between the
function value of the present generated valley to be explored and the last saved lowest
valley. The acceptance distribution decides probabilistically whether to stay in a new
lower valley or to bounce out of it. All generating and acceptance distributions depend on
the temperature. The structure of the simulated annealing algorithm is shown as Figure 4.
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Figure 4 The structure of the simulated annealing algorithm.[56]
The major advantage SA over other methods is an ability to avoid becoming trapped in
local minima. It is flexible and able to approach global optimality. Carefully controlling
the rate of cooling of the temperature, SA can find the global optimum. However, this
9

requires infinite time. Also, the evaluation of the problem functions is essentially a “black
box” operation as far as the optimization algorithm is concerned, because the SA
algorithm does not require or deduce derivative information. However, for many
applications, the computational efficiency is important. The standard implementation of
SA algorithm is one in which a collection Markov chain of finite length are generated at
decreasing temperatures.
1.3.3 Markov Chain Monte Carlo Methods
A Markov chain is a mathematical tool for statistical modeling in modern applied
mathematics. In a Markov chain, the next state depends only on the current state, with the
state changing randomly between steps. After sufficient amount of steps, the chain may
reach a stationary distribution where the probability values are independent of the actual
starting value. Since the system changes randomly, it is generally impossible to predict
the exact state of the system in the future. However, the statistical properties of the
system’s future can be predicted. In many applications, these statistical properties are
important.
Markov chain Monte Carlo (MCMC) methods are a class of algorithms for empirically
creating a probability distribution by constructing a Markov chain that has the desired
distribution as its equilibrium distribution. MCMC techniques provide random walks in
parameter space whereby successive steps are weighted by the likelihood of observing
data given the corresponding parameter values. They are widely used in the field of
Bayesian statistics where they provide an attractive option for assessing the uncertainty in
the model parameters given the calibration data.[51,53] One of the big challenge in the
application of Bayesian approach to more realistic problems, such as modeling biological
system networks, is computational efficiency. The computational efficiency of a MCMC
algorithm depends highly on the structure of the proposal distribution. One recent
advance in MCMC algorithms has been to improve the computational efficiency by
dynamically adjusting the proposal distribution from a non-informative prior distribution
at the start of the simulation to a proposal distribution that reflects the structure in the
cumulative Markov chain. These are called Adaptive MCMC methods. Klinke developed
10

and applied an empirical Bayesian approach to establish the confidence that one
particular mathematical model can describe signal transduction mechanisms in biological
signaling networks, given the available data [37]. In the study, an Adaptive Markov
Chain Monte Carlo (MCMC) techniques was used to assess the uncertainty in the model
parameters given the calibration data for the mathematical model by providing random
walks in parameter space whereby successive steps are weighted by the likelihood of
observing data given the corresponding parameter values. Bayesian approach has been
used to infer confidence of models for transcription factor activity and cellular signaling
networks. Monte Carlo integration was used to approximate posterior distribution
required for a Bayesian analysis. A Markov chain was generated, using the previous
sample values to randomly generate the next sample. Metropolis-Hasting algorithm can
be used to generate a Markov chain by random sampling. Typically the first 100000 to
500000 elements are in the burn-in or “learning” period. A poor choice of staring values
can greatly increase the required burn-in time. The values obtained by simulated
annealing were used as a starting point to generate Markov chains.
Sequential steps in a generated Markov Chain exhibit autocorrelation. To minimize the
effect of autocorrelation, a technique called “thinning” was used by selecting values from
the Markov Chain at every nth iteration [37]. Recursive calculation of the proposal
covariance of the Markov Chain during the MCMC run is improved by thinning. The
expected value for some property of a model can be calculated from the following
integral:

(3)
where f(Θ) is a generic function of the model parameters. In this case f(Θ) is a
deterministic function that provides a prediction of the dynamic trajectory of the system
in response to a stimuli, given a set of parameter values. This equation used in
conjunction with the posterior distribution in the model parameter provides an estimate of
the uncertainty in the model prediction, given a model of particular calibration data.
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The expected value is dependent on the particular formulation of the model, M, and the
data used in calibrating the model, Y. As not all combinations of parameters provide
realistic simulations, values for f (Θ) are weighted by distribution of parameters given M
and Y (i.e., the posterior distribution P (Θ|M, Y)). A Bayesian estimate of P (Θ|M, Y))
could be provided by computer-intensive methods like Monte Carlo algorithms. Markov
chain represents a random walk within parameter space. Recently developed AMCMC
can dynamically adjust the structure of the proposal distribution based upon the prior
steps of an evolving Markov chain. The prior distribution used in this study was the same
for all parameters, proper, normally distributed, and used to specify the initial proposal
distribution. Following a specified “learning” period, the proposal distribution was
adjusted to reflect the structure in the cumulative Markov chain.
However, deciding when the cumulative Markov chain is a representative sample drawn
from the underlying stationary distribution is still a big challenge with implementing a
MCMC approach for Bayesian inference. Convergence is a criteria used to evaluate how
long of a chain is necessary to traverse a representative sample of parameter space. Most
of algorithms developed diagnose the convergence of a Markov chain by focusing on the
model parameters. Klinke instead focused on the the predictions of the model to assess
convergence of Markov chains using Gelman-Rubin method. The Gelman-Rubin method
is based upon the concept that convergence has been achieved when the variance among
chains is less than within single chains.

12

CHAPTER 2
RESEARCH METHODS
2.1 Experimental Aspects
All biological experiments were done by Irina V. Ustyugova who was a graduate
student in John Barnet’s lab, Department of Microbiology, Immunology & Cell
Biology, West Virginia University, Morgantown, WV, USA
Cell culture, stimulation and DCPA treatment The murine peritoneal macrophage cell
line, IC-21, was cultured to 80% confluency in complete RPMI (cRPMI) Cells were
treated with 99% pure DCPA and simultaneously stimulated with 1 g/ml LPS phenol
extracted for various times. 100 M of DCPA were dissolved in 100% ethanol and
added to cells. The final ethanol concentration added to all cultures was 0.1%; control
cultures received equal concentrations of ethanol.
Nuclear Extracts
Cells were then treated with either 0.1% ethanol or 100 M DCPA, then stimulated with
1 g/ml LPS. Cells were washed. A total protein concentration for nuclear extracts was
determined with Coomassie Plus Protein Assay Reagent, as described by manufacturer
(Pierce, Rockford, IL).
Electrophoretic mobility shift assay (EMSA)
NF-κB consensus oligonucleotides were labeled with -32P-ATP using Ready-ToGoTM T4 polynucleotide kinase kit. Nuclear extracts, 5 g per sample, were incubated
with 50,000 cpm of labeled probe and 1 g/ml dI:dC to allow formation of band shift
complexes and electrophoresed. The EMSA experimental results are reported as the ratio
of the intensity measured for a particular condition (i.e. time > 0) relative to the intensity
of nuclear NF-κB prior to treatment (i.e. time = 0).
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Western Blotting of IкBα and IкBβ
After the nuclear extracts, IC-21 cells were treated as indicated, collected by
centrifugation, and washed two times with cold phosphate-buffered saline. Western blot
analysis was performed using the indicated antibodies of IкBα and IкBβ.
2.2 Mathematical Modeling Aspects
The application of mathematical models to describe NFкB-IкBs signaling mechanism
was pioneered by Hoffmann A [11], and extended by many others [13, 23]. This model
builds upon prior modeling studies by Lipniacki [13] but incorporates two key changes.
First, the reactions were grouped into reaction classes that are defined based upon peptide
motif-motif interactions [35]. Equal parameters are assigned to reactions in the same
class. Additional effect factors to some complexes reactions in the presence of NFкB are
considered, according published experimental data [36]. Second, dynamic equilibrium is
considered between protein-protein interactions. NFкB is considered as a single protein.
The interaction between IKK and IкBα as well as IкBαNFкB complex in the cytoplasm
effectively proceeded as a single enzymatic degradation reaction scheme:
E + S → ES → E
where E is the enzyme, IKKa (IKK in active status), S is the substrate (IкBα or
IкBαNFкB) and ES is the enzyme-substrate complex (IKKaIкBα or IKKaIкBαNFкB
complex). Three parameters are used to describe this process, including association rate,
a2, dissociation rate, d2 and catalytic rate, kcat. After this enzymatic process, IKKa is
regained but IкBα is lost while NFкB is released. The interaction between IкBα and
NFкB also consists in the forward and reverse reactions with rate a1 and d1. Dynamics of
IKK is represented as a module, where details of upstream signaling interaction are not
represented in detail. The description of all reactions is shown in supplement material 1.
2.3 Model Calibration
The reactions between all components associated with parameters were converted to a set
of non-linear ordinary differential equations. For the values of the parameters, some of
14

them are from literature published before, while a subset of parameters will be
determined from the experimental data. As many of the parameters are correlated, a
parameter identifiablity analysis described by Klinke [28] was used to establish the
parameters which can be uniquely determined, given unlimited information about the
model. Parameters that are not locally identifiable, termed a priori unidentifiable, have
correlation values less than -0.985 or greater than 0.985 with at least one other parameter.
Two models were built. Model 1 was built to describe the system by fitting experimental
data from IкBα and NFкB measured in IC-21 cells with and without DCPA treatment
following LPS stimulation. To further study the signaling mechanism, model 2 was built
to include also fitting IкBβ experimental data. Initial concentrations of the components
are needed to simulate the response. The initial concentration of NFкB is assumed as 0.06
μM in the cytoplasm [36]. All of NFкB is assumed to exist as IкBαNFкB for model 1 in
the cytoplasm. For model 2, the initial concentration of NFкB is assumed as 0.03 μM
кBαNFкB and 0.03 μM IкBβNFкB in the cytoplasm; the initial concentration of NFX is
assumed as 0.02 μM in the cytoplasm. All other components are assumed as zero. A 2000
minute period is simulated to get the equilibrium concentrations of all the variables
before the stimulation and DCPA treatment.
Unknown parameters obtained from the first model were used as a starting point to
simulate the second model. Experimental data of NFкB in the nucleus, IкBα in the
cytoplasm and IкBβ in the cytoplasm, measured previously in our lab, were used to
calibrate the model. More unknown parameters were identified by the simulated
annealing program. Simulated annealing is a robust and general technique to deal with
highly nonlinear models. The greatest advantage of this technique is the ability to
approach global optimality. The model equations are encoded and evaluated in MATLAB
V7.1 (The MathWorks, Natick, MA). Summed squared error between experimental data
measured previously in our lab and simulated measurements was used to determine
goodness-of-fit. The optimum values obtained from the simulated annealing were used as
a starting point for the Markov Chain [37].
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2.4 Bayesian Approach
After parameter identifiablity analysis, Simulated Annealing was used to find the
optimum fitness of the given experimental data for of NFкB in the nucleus and IкBα in
the cytoplasm. Metropolis-Hasting algorithm was used to generate possible states to be
explored in the parameter space. An acceptance distribution depends on the difference
between the function value of the present state to be explored and the last saved lowest
state. The acceptance distribution decides probability whether to stay in a new state or to
bounce out of it. The Simulated annealing program was used to produce the initial values
for the AMCMC algorithm, shown as Figure 5.
Using the results from Simulated Annealing program as the start point to generate a
Markov chain by An empirical Bayesian approach using Adaptive Markov Chain Monet
Carlo (AMCMC) algorithms, as described by Klinke [37]. The generated Chain by
Metropolis-Hasting algorithm is autocorrelative. To minimize the effect of
autocorrelation, a technique called “thinning” was used by selecting values from the
Markov Chain at every nth iteration. Recursive calculation of the proposal covariance of
the Markov Chain during the MCMC run was improved by thinning. The thinning value
used to estimate the covariance recursively from the evolving Markov chain is 40. To
obtain P(Θ|Y,M) from the final Markov chains, a thinning value of 20 was used.
The prior distribution used in this study was the same for all parameters, proper, normally
distributed, and used to specify the initial proposal distribution. Following a specified
“learning” period, the proposal distribution was adjusted to reflect the structure in the
cumulative Markov chain. How a Monte Carlo Markov chain is generated is as same as
description by Klinke [37]. The Gelman-Rubin method is then used to analyze the
convergence of the model using two parallel chains. The first N steps, called “learning
period” or “burn-in period”, are discarded as they are assumed to be drawn from tails of
the stationary distributions. The remainder of the parallel chains was used to estimate the
convergence of the predictions to a stationary distribution. Two parallel Markov chains
were calculated each containing 900,000 steps. The simulation of each chain took
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approximately 500 hours on a single core of a 2.66 GHz Dual-Core Intel Xeon 64-bit
processor with 8 GB RAM.

Figure 5 The AMCMC algorithm structure for our model
The parameter values obtained using simulated annealing provided the starting point for
these chains. A “learning” (a.k.a. “burn-in”) period of 250,000 steps was specified a
priori to provide an initial estimate for the proposal covariance.
To estimate convergence, the prediction PYij obtained from a single draw from J parallel
MCMC samples of length N, where j

N and i

N. The overall variance of prediction,

Var(PY), derived from the target distribution is estimated from the between-sequence (B)
and the within-sequence (W) variances. The Gelman-Rubin Method diagnoses
convergence from the potential scale reduction factor is calculated as follows:
17

R = Var(PY) / W
where parallel chains of length N should be increased until R is less than 1.2.
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CHAPTER 3
RESULTS AND DISCUSSION
3.1 Analysis of the experimental data
Experimental results (measured previously in our lab by Irina V. Ustyugova)

Figure 6 Initial experimental results. (A) NFкB in the nucleus measured by
Electrophoretic mobility Shift Assay (EMSA); (B) IкBα, IкBβ and β-actin which
was used to normalize IкBα and IкBβ, in the cytoplasm measured by western
blotting. E represents ethanol treatment while D represents DCPA treatment.
The changes of NFкB concentration in the nucleus of IC-21 macrophages were
measured following LPS stimulation or LPS stimulation and DCPA treatment for period
of 6 hours using electrophoretic mobility shift assay, shown as in Figure 6 (A). The
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concentration change of IкBα and IкBβ proteins in the cytoplasm of IC-21 cells were also
measured by western blot, shown as B in Figure 6. Ethanol treatment following LPS
stimulation was used as control experiments. 100 µL DCPA was used to test the effect of
DCPA on NFкB activity in macrophages.
Differential dynamics of IкBα and IкBβ were observed following LPS stimulation for
both ethanol and DCPA treated IC-21 cells. From Figure 6, we can see that following
LPS stimulation with or without DCPA treatment (both of LPS and DCPA or ethanol
were added at time 0), IкBα (middle band) concentration decreased and then rebounded
more rapid than IкBβ (top band). All these experimental data are numerically
summarized as Figure 7. From Figure 7, we can see clearly that the increase of free
nuclear NFкB concentration starts after 5 minutes, which is following the decrease in
IкBα. The cytoplasmic IкBα reaches the lowest concentration earlier than free nuclear
NFкB reaches its highest concentration. Following free nuclear NFкB, which is thought
to be the active form with the ability to promote the productions of other proteins,
cytoplasmic IкBα concentration recovers to a level close to that before the LPS
stimulation. Following the resynthesis of cytoplasmic IкBα, the active NFкB
concentration decreases. Whether the cells were treated with or without DCPA, the
nuclear NFкB concentration shows oscillation and reaches a high level of constant
activity after about 3 hours. This higher level of NFкB activity is about 8 times as that
before the stimulation. This oscillation behavior of nuclear NFкB was also observed by
other groups in other kind of cells.[10,11,15,18] Hoffman’s study demonstrates that, in
fibroblasts, the negative feedback effect of IкBα on the NFкB activity signaling network
cause the oscillation while IкBβ and IкBε dampen the oscillations and stabilize NFкB
during longer stimulations.[11]
We also measured cytoplasmic IкBβ concentration following LPS stimulation in IC-21
cells shown in Figure 7 C. Unlike IкBα, the decrease of IкBβ concentration following
LPS stimulation is much slower. After about 90 minutes following the stimulation, the
concentration of IкBβ begins to rise, at a rate that is much slower than the rising of IкBα
concentration. IкBβ concentration keeps rising to a level higher than that before LPS
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Figure 7 Summary of experimental data and normalized by the concentration
before LPS stimulation (A) Nuclear NFкB (NFкBn); (B) Cytoplasm IкBα; (C)
Cytoplasm IкBβ. Red squares represent experimental results with DCPA
treatment while black dots represent ethanol treatment.
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stimulation, while IкBα and the active NFкB concentration oscillate slightly around the
constant level. Active NFкB in the nucleus induces IкBα and IкBβ transcription. Resynthesized IкBα proteins bind to free NFкB in the cytoplasm to keep it in the cytoplasm.
Re-synthesized IкBα proteins can also go to the nucleus to export free NFкB to the
cytoplasm.[11,19] The negative feedback effect of IкBα causes the oscillation of NFкB
activity. IкBα and IкBβ have distinct functions in regulating NFкB activity. [10]
However, the mechanisms of IкBα and IкBβ regulation and how they regulate NFкB
activity are still not clear.
The different dynamic profiles of IкBα and IкBβ following an external stimulation were
also observed by other groups.[10,11,23] According to Kearns’s study,[23] NFкB is
essential both for IкBα and IкBβ mRNA transcription. In the wild-type cells, the IкBβ
mRNA level remains constant for about 45 minutes after chronic TNFα stimulation,
while IкBα mRNA level rises immediately. This is consistent with our observations on
IкBβ protein level in the cytoplasm. We observed a 60 minute delay in resynthesis
compared with IкBα following the LPS stimulation.
The profile of nuclear NFкB in the cells exposed to DCPA looks similar but a little ahead
of time compared to cells without DCPA treatment. In [28], it was demonstrated that
DCPA has the ability to potentiate an early NFкB activity. Moreover, Klinke and
coworkers demonstrate that an EMSA assay lacks the sensitivity to detect change in early
NFкB activity. However, how the DCPA affects NFкB activity is still unknown.[27] Not
surprisingly our EMSA results suggest that free NFкB concentration was not
significantly decreased by DCPA treatment following LPS stimulation. As shown in
Figure 7 B, IкBα concentration decreased quickly following the stimulation and increased
immediately after NFкB activated. Differences in IкBα expression upon DCPA treatment
do not become apparent until 3 hours following LPS stimulation. But in the first three
hours of the LPS stimulation and DCPA treatment, the decrease is not that obvious.
Compared with IкBα, IкBβ concentration decreased relatively slowly and following a
delay, increased more slowly, shown as Figure 7 C. After 6 hours’ stimulation, IкBβ
concentration in the cytoplasm increased to a level greater than before the stimulation.
The dynamics profile for IкBβ is different from the IкBα dynamics profile, whereby a 60
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minute delay was observed in cytoplasmic IкBβ protein level following NFкB activity.
From the western blot image, two form of IкBβ with different dynamics can be
recognized, as shown in Figure 6 B, but are summed together as the total cytoplasmic
IкBβ. Furthermore, DCPA treatment also decreased cytoplasmic IкBβ concentration
following LPS stimulation. The significant decrease by DCPA treatment started from 90
minutes, a little earlier than IкBα. We also noticed that the resynthesis of cytoplasmic
IкBβ concentration starts at 90 minutes following the LPS stimulation with or without
DCPA treatment and is about 60 minutes later than cytoplasmic IкBα concentration
resynthesis. The slower decrease and delayed resynthesis of cytoplasmic IкBβ suggest
that the contribution of this negative feedback mechanism is not a major contributor to
the observed dynamics of NFкB activation during the first 90 minutes following LPS
stimulation. In the first 90 minutes, IкBα appeared to be more important in regulating
NFкB activity than IкBβ at the beginning. Therefore, in IC-21 cells, IкBα protein is a key
early regulator of NFкB activity. However, the mechanism of how IкBα regulating NFкB
is still unclear. To help understand the process, we developed a mathematical model to
describe the first 90 minutes following extracellular stimulation. IкBα is more important
as a negative feedback to regulate NFкB activity at the beginning period following LPS
stimulation. Therefore, our initial effort to expand the mathematical model of NFкB
activity in IC-21 cells included the contribution of IкBα alone. Using this model we
focused on the dynamics of NFкB and IкBα in the first 90 minutes with and without
DCPA treatment and used the model to predict the rest of the stimulation time (Model 1).
IкBα was used to represent the functions of inhibition of NFкB activity. We also
compared the difference of the two sets of parameter values that fit experimental data of
NFкB and IкBα to identify difference induced by DCPA treatment. Finally we extended
the model to incorporate both IкBα and IкBβ and their distinct functions and dynamics.
As suggested experimentally, IкBβ starts to play an important role on regulating NFкB
activity after 90 minutes.
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3.2 Model topology
3.2.1 Mathematical Models development
Following from experimental observation, the IкBβ resynthesis occurred after 90 minutes
following LPS stimulation; therefore, we built two models.
Model 1
The first model was developed based on the simple model published by Klinke[28], but
more proteins and mRNAs were added to describe the signaling network of NFкB
activity. In model 1, we focused on the first 90 minutes following LPS stimulation and
postulate that IкBα represents the major regulator of IкB proteins at this period; for
model 2, we included both IкBβ and IкBα as regulatory elements for NFкB. The
schematic diagram of model 1 is shown in Figure 8. Activation of NFкB following LPS
stimulation of the cells is depicted as a binary on/off stimulus. Before the stimulation, the
activity of TLR4 is set to zero (off). During the whole LPS simulation period, TLR4 is
kept as 1. Following the stimulation, LPS binding to TLR4 activates the signaling
network, transferring IKK from a neutral form, IKKn, to the active form, IKKa. Active
IKK phosphorylates free IкBα, bound IкBα, and IкBβ. The presence of NFкB makes the
phosphorylation more efficient.[21] Free NFкB dynamically shuttles between the
cytoplasm and the nucleus; within the nucleus, free NFкB binds to DNA, promoting the
transcription and translation of numerous proteins including IкBα, IкBβ and A20. Newly
synthesized IкBα goes to the cytoplasm, binding to NFкB to prevent its nuclear
localization or shuttles to the nucleus to inhibit its binding to DNA and exporting it out of
the nucleus. Newly synthesized A20 inhibits IKK activity.
The first model consists of 14 components, as listed in Table A.1 in APPENDIX: three
status of IKK including IKKn(neutral), IKKa(active), IKKi(inactive), NFкB, IкBα, A20
and their complexes, IKKaIкBα, IкBαNFкB, IKKaIкBαNFкB, IкBαn, IкBαnNFкBn and
NFкBn, ( n means in the nucleus), and the following mRNAs: IкBαm and A20m(m
denotes mRNA). IKKn(neutral) can be activated to IKKa(active), or deactivated to
IKKi(inactive), which are not reversible. Biological events in this model are converted to
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25 groups of reactions listed in Table A.2 in APPENDIX; and concentration changes of
these components are calculated using differential equations as shown in Table A.3 in the
APPENDIX.
Model 2
Based on the first model, the second model including the regulation of IкBβ was built to
capture experimental data in the whole stimulation period. Since less is known about
IкBβ, most of its properties are assumed based on IкBα. But one major difference with
IкBα is proposed. The delay in IкBβ mRNA synthesis was due to an unknown
intermediate transcription factor (NFX), whose synthesis was dependent on NFкB
activation. Therefore, we assume that NFX can shuttle between the nucleus and the
cytoplasm. NFX is NFкB inducible and promotes the transcription and translation of
IкBβ responsible. The schematic demonstration of the second model is shown in Figure 9.
Before the stimulation, IкBβ exists in the cytoplasm and similar to IкBα is bond to NFкB.
Active IKK phosphorylates IкBβ to release NFкB. In contrast to IкBα and, IкBβ is
induced through an intermediate nuclear factor NFX. New synthesized IкBβ proteins
enter the cytoplasm, binding with free NFкB to inhibit its activity. In this model, we
assume that IкBβNFкB can shuttle between the cytoplasm and the nucleus, while IкBβ
could shuttle between the cytoplasm and the nucleus, and bind to nucleus NFкB and
promote the export of this complex from the nucleus.
After classifying biochemical reactions, 46 groups of reactions are converted to describe
the concentration change of 24 components, as shown in table 1 and 2. Differential
equations being used to describe the rates of change of the concentrations of these
components are shown in Table A.4 in APPENDIX.
For the big model, because of too many unknown parameters and most of them may be
correlated, the simulation annealing program couldn’t get a good fit for all the three data
sets, free NFкB, IкBα and IкBβ. Otherwise, more steps are needed to get the best fit
efficiently. MCMC sampling may help in this way.
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Figure 8 Schematic demonstration of the model 1for NFкB signaling following the LPS
stimulation. A schematic diagram of the biochemical events represented in the
mathematical model represented using Cell Designer 4.1. The model represents
synthesis of IкBα and A20, association and dissociation between IкBα + IKKa, IкBα +
NFкB, and IKKa + IкBα + NFкB, and the degradations of IKK, IкBα and A20 proteins,
and IкBα and A20 mRNAs, and transcriptions of IкBα and A20 mRNAs and
transportations of IкBα and NFкB between the nucleus and the cytoplasm.
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Figure 9 Schematic demonstration of the model 2 for NFкB signaling. Besides IкBα
as an inhibitor to NFкB, IкBβ was added to the signaling network. The interactions
between IкBβ, NFкB, and IKKa were added into the model 1. Further, an unknown
nuclear factor NFX was proposed to promote IкBβ mRNA transcription. The
synthesis, degradation and transportation of NFX were also included in the diagram
of the signaling network by Cell Designer 4.1.
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3.2.2 Model Calibration
The mathematical models, shown schematically in Figure 6 and 7, were calibrated against
values obtained from experimental data measured previously in our lab. The values were
obtained with IC-21 cells (macrophage cell line) in response to 1 μg/ml LPS with 100 μM
ethanol (as control experiment) or with 100 μM DCPA. Nucleus NFкB was measured by
EMSA while total IкBα and IкBβ in the cytoplasm were measured by western blot. Initial
data is shown in Figure 6, while the numerical summary is shown in Figure 7. The
mathematical models were implemented in MATLAB as detailed in supplement 2.
Maximum likelihood values for the parameter were determined using simulated
annealing. The specific parameter values are shown in Table 3.2. An empirical Bayesian
approach was used to estimate the uncertainty in the model parameters given the
available calibration data.
3.2.3 “A priori” identifiability analysis
Sensitivity analysis (SA) is the study of how the variation (uncertainty) in the output of a
mathematical model can be apportioned, qualitatively or quantitatively, to different
sources of variation in the parameters, either rate constants or initial conditions associated
with a model. Based upon how the model is constructed, different parameters influence
the output of the model in the same way. These parameters that cannot be estimated
separately are called unidentifiable parameters.
Correlation of the unknown parameters in model 1 was analyzed and the results are
shown in Table 3.1. This symmetric table represents a correlation matrix where each
element in the table represents the correlation between the two parameters in the row and
in the column. If the absolute value greater than 0.95, we will consider these two
parameters are nonidentifiable. From the table, we can see that some parameters are not
correlated to any other parameters. For instance, k2 which associates with IKK
inactivation via A20, has correlation values with other parameters all smaller than 0.95.
Therefore, it is not correlated to any other parameters in this model and can be identified.
On the other side, some of parameters are correlated, which are unidentifiable. For
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instance, s1, which represents the inducible production of IкBα mRNA, and t1, which
represents the translation rate of IкBα, are completely correlated (0.999). For instance,
the effect of slow IкBα mRNA production on the observed cytoplasmic IкBα and nuclear
NFкB concentration could be compensated by fast translation of IкBα mRNA to IкBα
protein. Whether the production is slow and the translation is fast or the translation is
slow and the production is fast will have the same effect on the observed cytoplasmic
IкBα protein concentration. Therefore, we cannot uniquely determine s1 and t1 given the
mathematical structure of the model. However, as we don’t have enough information
about these parameters, we allow the simulation annealing algorithms to estimate them
and optimize the fitness of the model to experimental data. Then AMCMC will be used to
estimate the uncertainty in the model parameters.

Table 3.1 Correlation analysis of unknown parameters in Model 1
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Table 3.2 Comparison of the parameter values fit to the two experimental conditions.
There values represent the maximum likelihood values as determined using simulated
annealing.
Parameters

Definition

Without DCPA

With DCPA

s1

IκBα inducible synthesis rate

3.80e-3

2.95e-5

cs1

IκBα constitutive synthesis rate

3.00e-12

2.57e-13

t1

IκBα translation rate

3.00e-4

8.23e-1

s2

A20 inducible synthesis rate

314.22

0.24

cs2

A20 constitutive synthesis rate

3.13e-4

1.65e-11

dm2

A20 mRNA degradation rate

28.23

0.16

t2

A20 translation rate

3.10

0.59

k1

IKK activation rate

0.93

2.71e-4

k2

IKK inactivation rate by A20

0.59

0.37

k3

IKK spontaneous inactivation rate

3.00e-7

1.33e-18

kprod

IKKn production rate

0.16

6.94e-4

kdeg

IKKa, IKKn and IKKi degradation

0.10

8.7e-4

e1a

IκBα nuclear import rate

4.48e-4

1.21e-4

i1

IκBα nuclear export rate

3.10e-3

5.04e-4

e2a

IκBαNFκB nuclear export rate

1.10e-3

6.80e-3
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3.2.4 Results of Simulated Annealing
The simulation results for model 1 are compared against the experimental data without
DCPA are shown in Figure 10. The first 90 minutes of total IкBα in the cytoplasm and
free NFкB in the nucleus following the LPS stimulation were used to select parameter
values using simulated annealing. The resulting simulation is compared against the whole
6 hours observation period in Figure 10.
As shown in Figure 10, the simulation response was based on the first 90 minutes
experimental data, can still predict NFкB activity well for the rest of 6 hrs after the
stimulation. However, the model predicts higher levels of cytoplasmic IкBα data after 90
minutes than was experimentally observed. In other words, additional inhibitors besides
IкBα are needed to keep NFкB activity as measured.

Figure 10 Simulation results for model 1 compared with experimental data without
DCPA treatment using simulated annealing program. Line curves are the simulation
results respectively for total IкBα in the cytoplasm and free NFкB in the nucleus. The +
symbols are the experimental data of total cytoplasmic IкBα, while the о symbols are the
experimental data of free nuclear NFкB.
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The simulation results for the experiment with DCPA treatment is shown in Figure 11.
The simulation results for the experimental data with DCPA treatment suggest an
enhanced dampening of the NFкB oscillations as compared to without DCPA treatment,
while the overall agreement between model and data is not particularly good.

Figure 11 Simulation results for model 1 compared with experimental data with DCPA
treatment by simulated annealing program. Line curves are the simulation results
respectively for total IкBα in the cytoplasm and free NFкB in the nucleus. The + symbols
are the experimental data of total cytoplasmic IкBα, while the о symbols are the
experimental data of free nuclear NFкB.
From table 3.2, we can see most of the parameter values are much different for
experiments without DCPA and with DCPA. Except k2, e1a and e2a are in the same level,
all other parameter are much different. It is difficult to say which parameters are changed
by DCPA. Even values for some parameters are much different, the simulated results
against the two experimental conditions are still in the same level. For example, the
transcription of IкBα mRNA, s1 and the translation of IкBα rnRNA should be correlated.
For experimental data without DCPA treatment, s1 is 3.8e-3 and t1 is 3.0e-4, while for
experimental data with DCPA treatment, s1 is 2.947e-5 and t1 is 8.229e-1. A small
production rate needs a big translation rate to get the similar the protein production level.
To further decide which parameters are identifiable, a priori identifiably analysis was
used to determine which parameter could be structurally indentified.
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3.3 Results of AMCMC
A series of Markov chains generated using Metropolis-Hasting algorithm were used to
estimate the conditional uncertainty in the model parameters given the experimental data
with and without DCPA treatment. The proposal distribution is scaled dynamically to
achieve an acceptance fraction of 0.2. The trace of the acceptance fraction is shown as a
function of AMCMC step, in Figure 12 (A, C). The trace of the covariance scaling factor
is shown as a function of AMCMC step, in Figure 12 (B, D). The trace of the acceptance
fraction demonstrates that the scaling factor was adjusted at regular intervals to maintain
the acceptance fraction around 0.2.
The trace of the conditional probability for each of the two chains against experimental
data with and without DCPA treatment, shown in Figure 13, the better the fitness is, the
greater the P(Y|Θ,M) is. From the results, chain 2 fits the results better than Chain 1.
The Gelman-Rubin potential scale reduction factor (PSRF) was applied to the model
predictions to access the convergence of the cumulative Markov Chains.[37] The
Gelman-Rubin PSRF statistics were calculated for the species observed experimentally as
a function of time and AMCMC step and shown graphically as a contour plot in Figure
14.
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Figure 12 Evolution of the performance of the AMCMC algorithm. AMCMC model fits
for DCPA treated (panels C and D) and untreated cells (panels A and B) are shown
separately. The proposal covariance scaling factor (B, D) and the acceptance fraction
(A, C) are shown as a function of AMCMC step against experimental data. The results
for each of the two parallel chains are shown in different colors: chain 1 (Red) and chain
2 (Blue).
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Figure 13 Evolution in the likelihood, P(Y|Θ,M), as a function of AMCMC step. The
normalized likelihood value is shown as a function of AMCMC step for both two parallel
chains against experimental data without DCPA treatment. The results for each of the two
chains are shown in different colors: chain 1(Blue), chain 2(Red).
The colored contours correspond to values of the PSRF. The model predictions exhibited
a potential scale reduction factor of below 1.2 immediately after the “learning” period.
The variability among chains, as represented by an increase in PSFR, increased as a
function of simulation time, existed for both NFкB and IкBα. This behavior was due to
under-sampling at longer times relative to earlier times. For comparison, the 95th
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percentile, 5th percentile, and median responses for each of the two chains are overlaid
upon the experimental data without DCPA treatment in Figure 15. Traces for each of the
parameters are shown in Figure 16. Density distribution for the model parameters is
shown in Figure 17. Covariance structure of P (Θ|Y) is shown in Figure 18.

Figure 14 Gelman-Rubin assessment of the Convergence of AMCMC . A contour
plot of the Gelman-Rubin statistic applied to the model predictions is shown as a
function of time (i.e., the y-axis) and as a function of the cumulative chain up to a
specific AMCMC step (i.e., the x-axis). Two parallel chains were used to calculate
the Gelman-Rubin statistics for the simulated (panels A and C) Free NFкB
expression in the nucleus and (panels B and D) total IкBα in the cytoplasm. Values
less than 1.2 suggest convergence of the chains.
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Figure 15 The mathematical model 1 for early signaling events reproduces the early
dynamics for activation of NFкB. Simulated results (lines) are compared against the
experimental observations without DCPA treatment (symbols). The uncertainty in the
model predictions obtained from each chain is represented by three lines of the same
color: the most likely prediction is represented by the solid lines and the dashed lines
represent the 95th and 5th percentile of the predicted response. The results for each of
the three parallel chains are shown in different colors: chain 1 (Red), chain 2 (Blue).
(A, C) Simulated response (lines) versus measured free NFкB (squares) in the
nucleus; (B, D) Simulated response (lines) versus measured total IкBα (squares) in the
cytoplasm.
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In Figure 14, the Gelmn Rubin statistic suggests convergence between the two chains at
the initial start point. At longer times the two predictions from the two chains diverge. In
Figure 16, the trace of the parameters suggests that the accepted parameter values are
very different for the two chains.
The posterior distribution in the predictions (see in Figure 15) shows that even both
chains (red and blue) reproduce most the experimental data in the first 90 min, but their
oscillation frequencies are much different. The blue chain fits the NFкB data better while
the red chain fits the IкBα data better. It seems that the frequencies of these two sets of
data are different. One chain tries to catch the frequency of one set data while the other
tries to catch the frequency of the other one. Even after 1 million steps, these two chains
still can’t find a set of parameter values to fit both frequencies. According to Hyyot’s
work[54] and Nelson’s study[55], the external stimulations can cause the frequency of
NFкB to vary a lot. Because NFкB and IкBα were measured on different dates, a slight of
difference of the LPS stimulation maybe cause the variance of signaling frequency.
From the normalized error of the model prediction, shown as Figure 17, we can see that,
the ranges of parameters in the blue chains are much bigger than those of the red one. The
blue chain has a difficult time to find a best fitness for both of the data. This is also
because of the correlations among parameters in the signaling network. From the
Covariance structure of P (Θ|Y), shown as Figure 18, we can also see that most of the
parameters are correlated, which is consistent with the results from the a priori
identifiably analysis.
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Figure 16 AMCMC summary plots for each of the model parameters for model 1
without DCPA treatment. The trace of each of the model parameters is shown as a
function of MCMC step. The traces for two parallel chains are shown in different
colors: chain 1 (Red) and chain 2 (Blue).
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Figure 17 Normalized Distributions in Parameters for model 1 without DCPA treatment.
The distribution in the sum of the normalized error between the calibration data and the
model predictions is shown for each study used in the analysis. Distribution for the two
parallel chains against experimental data without DCPA treatment is shown in different
colors: chain 1(Blue) and chain 2(Red).
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Figure 18 Covariance structure of P (Θ|Y) for model 1 without DCPA treatment. The
pairwise correlation coefficients of the parameters derived from all two thinned (Kthin =
200) Markov chains are shown above the diagonal. A high value for the correlation
coefficient suggests that the parameters are unidentifiable given the calibration data.
Below the diagonal, pairwise projections of the marginalized probability density for P
(Θ|Y) are shown. The parameter names are shown on the diagonal. Each scatter plot axis
spans a range of 1012(i.e., (log-mean-6.0 to log-mean+6.0)).The values in each scatter
plot are centered at the log-mean values (i.e., the expectation maximum) determined from
two parallel Markov Chains each containing 900,000 MCMC steps.
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Figure 19 AMCMC summary plots for each of the model parameters for experimental
data with DCPA treatment. The trace of each of the model parameters is shown as a
function of MCMC step. The traces for two parallel chains are shown in different colors:
chain 1 (Red) and chain 2 (Blue)
For the experimental data with DCPA treatment, we also did MCMC sampling to
compare with the result for experimental data with DCPA treatment. From the
convergence plot, shown as Figure 14, we can see that some of points are converged
while some of them are not. Combined with the prediction of the simulation results,
shown as Figure 15, although both chains could fit most of the data points, the frequency
vary so much that they are not converged at other time points. From that we can also
expect the parameter values also vary a lot, shown as in Figure 19 and Figure 20.
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Figure 20 Normalized Distributions in Parameters for experimental data with DCPA
treatment. The distribution in the sum of the normalized error between the calibration
data and the model predictions is shown for each study used in the analysis. Distribution
for the two parallel chains are shown in different colors: chain 1(Blue) and chain 2(Red)
Using the first 90 minutes’ experimental data to estimate the values of the parameter and
the rest of 6 hours experimental period has some limits like the oscillation frequency of
NFкB activity and the prediction vary much. To further test the model, we applied the
AMCMC algorithm to the data of the whole 6 hours experimental period. From the
results for with and without DCPA treatment, we can see that the model predictions are
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more consistent compared with that only using the first 90 minutes of data, shown as
Figure 21 and Figure 22. However, even the model are more converged, but from the
trace of all the parameters, shown as Figure 27, the parameters sampling by two chains
are in two different valleys.

Figure 21 - Convergence of AMCMC . A contour plot of the Gelman-Rubin statistic of
the model predictions as a function of time (i.e., the y-axis) calculated as a function of
the cumulative chain up to a specific AMCMC step (i.e., the x-axis). Two parallel
chains were used to calculate the Gelman-Rubin statistics for the simulated Free
NFкB(panels A, C) expression in the nucleus and total IкBα (panels B,D) in the
cytoplasm without and with DCPA treatment. Values less than 1.2 suggest convergence
of the chains. The models were fit to the entire six hour time period following ;PS
stimulation without and with DCPA treatment.
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Figure 22 The mathematical model 1 for early signaling events reproduces the early
dynamics for activation of free NFкB expression (A, C) in the nucleus and IкBα (B, D) in
the cytoplasm. Simulated results (lines) are compared against the experimental
observations (symbols) used to calibrate the mathematical model for the entire 6 hours
experimental data without DCPA treatment (panels A and B) and with DCPA treatment
(panels C and D). The uncertainty in the model predictions obtained from each chain is
represented by three lines of the same color: the most likely prediction is represented by
the solid lines and the dashed lines represent the 95th and 5th percentile of the predicted
response. The results for each of the three parallel chains are shown in different colors:
chain 1 (Red), chain 2 (Blue).
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Figure 23 AMCMC summary plots for each of the model parameters for experimental
data without DCPA treatment. The trace of each of the model parameters is shown as a
function of MCMC step. The traces for two parallel chains are shown in different colors:
chain 1 (Red) and chain 2 (Blue).
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Figure 24 The mathematical model 2 for early signaling events reproduces the early
dynamics for activation of NFкB. Simulated results (lines) are compared against the
experimental observations (symbols) used to calibrate the mathematical model. The
uncertainty in the model predictions obtained from each chain is represented by three
lines of the same color: the most likely prediction is represented by the solid lines and the
dashed lines represent the 95th and 5th percentile of the predicted response. The results
for each of the three parallel chains are shown in different colors: chain 1 (Red), (A)
Simulated response (lines) versus measured free NFкB (squares) in the nucleus without
DCPA treatment; (B) Simulated response (lines) versus measured total IкBα (squares) in
the cytoplasm without DCPA treatment; (C) Simulated response (lines) versus measured
total IкBβ (squares) in the cytoplasm without DCPA treatment.
According Peng group’s work, Foxj1 is essential to IкBβ transcription.[24]
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Combine the measured cytoplasmic IкBβ data, which re-increased after 90 minutes
following the LPS stimulation, IкBβ should play an important role to regulate NFкB
activity in IC-21 cells after 90 minutes following the LPS stimulation. Therefore, to
better understand the regulation of NFкB activity in macrophages, IкBβ should be
included into the signaling network.
For the big model, to involve IкBβ in the signaling network, more parameters are
introduced, which causes more calculation in the modeling progress. From our current
MCMC prediction, we can see that the big model couldn’t catch the second peak of
NFкB. However, it gives a good simulation of the trend of all NFкB, IкBα and IкBβ
following LPS stimulation in macrophages. More experimental data are needed to
estimate some parameters to reduce the number of being-fitted parameters.
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CHAPTER 4
Conclusion

4.1 Regulation of NFкB activity following LPS stimulation

Macrophages play an important role in the immune system. NFкB is an essential nuclear
transcription factor in many kinds of cells including macrophages. NFкB induces or
promotes the productions of lots of proteins. Conversely, the activity of NFкB is also
regulated by other proteins. From our experimental data, IкBα proteins play a major role
in regulating NFкB activity. Our mathematical Model 1 works well by using the first 90
minutes data to predict the rest of the 6 hours’ experiment measured free NFкB in the
nucleus and total IкBα in the cytoplasm. Further, the stimulation results show that
additional proteins besides IкBα are needed to keep the NFкB activity in the level as
measured after 90 minutes following the LPS stimulation. This result is consistent with
our experimental results which showed that IкBβ proteins are produced 90 minutes after
LPS stimulationand eventually rise to a higher level than that before the LPS stimulation.
Therefore, we conclude that IкBα proteins are playing a major role in regulating the
NFкB activity in the beginning of the LPS stimulation and then IкBβ proteins become
more important as the time increases.

4.2 Mathematical Modeling of NFкB signaling network

Based on our conclusion from experiment measured NFкB, IкBα and IкBβ, we
developed two mathematical models, model 1 and model 2. In model 1, IкBα represent
the role of inhibitors of NFкB and is also induced by NFкB. A20 is used to regulate IKK
activity and also induced by NFкB. Two negative feedbacks involve 14 components and
25 groups of reactions. Twenty seven parameters are associated with these reactions
between the 14 components. From simulation annealing results, model 1 works well for
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the NFкB signaling. Furthermore, more IкBα proteins are predicted than measured,
which is consistent with the increased IкBβ proteins measured by the experiment. Model
2 uses an unknown nuclear factor NFX to introduce IкBβ mRNA and also cause the
delay of IкBβ mRNA transcription, comparing with IкBα mRNA. Model 2 includes 46
groups of reactions, translations and transportations. The simulation annealing program
was not able to select appropriate simulate this high dimensional model. We used MCMC
sampling to fit the model and could simulate for all NFкB, IкBα and IкBβ, as measured
by the experiment. However, the fit was not good enough to catch most of the observed
dynamics. More information about the parameters in the signaling network and the
unknown nuclear factor NFX is needed to further improve Model 2.
From the a priori identifiability analysis, some of these parameters in Model 1 are
correlated to each other. Comparing the parameter values fitted by the simulation
annealing program, they are much different for the experimental data without DCPA and
with DCPA treatment. It is difficult to say whether these differences are because of the
DCPA effect or just a result of the correlation between parameters. Similarly, we can
expect parameters are correlated in the Model 2, too.

4.3 AMCMC to estimate the conditional uncertainty in the model parameters

Two parallel Markov chains generated using Metropolis-Hasting algorithm were used to
estimate the conditional uncertainty in the model parameters against experimental data
with and without DCPA treatment. Using data of the first 90 minutes following the LPS
stimulation, the model doesn’t converge, although it could catch most of the data points.
The frequency of the predicted oscillations varies a lot between different chains. This
may be because of the frequency of the two data sets NFкB and IкBα were measured
under slightly different conditions. Slight difference in the external stimulation by LPS
may cause the difference of frequency of these two data sets.
However, when we include all the data from the whole 6 hours experiments, the
convergence of the model is improved. The predictions of the two chains for
experimental data with and without DCPA are much more consistent. However, the
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improved fit may be due to inclusion of additional parameters into the model. Model
discrimination criteria should be used to compare these two models. Overall more
information about parameters will help to estimate the unknown parameters and predict
the system.
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APPENDIX
Table A.1 List of Models Variables
Variable Name

Definition

Units

TLR4

Toll-like receptor 4

1

R0

LPS Stimulation signal

-

IKKn

Free neutral cytoplasmic IKK proteins

μM

IKKn

Free active cytoplasmic IKK proteins

μM

IKKn

Free inactive cytoplasmic IKK proteins

μM

IkBa

Free cytoplasmic IkBa proteins

μM

NFkB

Free cytoplasmic NFkB

μM

IKKaIkBa

Cytoplasmic IKKa-IkBa complexes

μM

IKKaIkBaNFkB

Cytoplasmic IKKa-IkBaNFkB complexes

μM

A20

Cytoplasmic A20 proteins

μM

A20m

A20 mRNA

μM

IkBam

IkBa mRNA

μM

IkBan

Free Nuclear IkBa proteins

μM

NFkBn

Free Nuclear NFkB

μM

IkBaNFkB

Cytoplasmic IkBaNFkB complexes

μM

IkBanNFkBn

Nuclear IkBa-NFkB complexes

μM

IkBb (#)

Free cytoplasmic IkBb proteins

μM

IkBbNFkB (#)

Cytoplasmic IkBbNFkB complexes

μM

IKKaIkBb (#)

Cytoplasmic IKKa-IkBb complexes

μM

IKKaIkBbNFkB (#)

Cytoplasmic IKKa-IkBaNFkB complexes

μM

IkBbm (#)

IkBb mRNA

μM

IkBbn (#)

Free Nuclear IkBb proteins

μM

IkBbnNFkBn (#)

Nuclear IkBb-NFkB complexes

μM

NFX (#)

Unknown transcription factor X

μM

NFXn (#)

Nuclear unknown transcription factor X

μM

NFXm (#)

Unknown transcription factor X mRNA

μM

(#) represents the components which are involved only in Model 2.
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Table A.2 Reaction rate equations of Model 1 and Model 2 for NFкB signaling pathway
Reaction

Rate Relationship

Reaction class 1: IkBa-NFkB Association
R1a = a1 * NFkB * IkBa
R1b = a1 * NFkBn * IkBan
R1c = a1 * NFkB * IKKaIkBa

Reaction class 2: IKKa-IkBa Association
R2a = a2 * IKKa * IkBa
R2b = a2 * f1 * IKKa * IkBaNFkB

Reaction class 3: IkBa-NFkB dissociation
R3a = d1 * IkBaNFkB
R3b = d1 * IkBanNFkBn
R3c = d1 * IKKaIkBaNFkB

Reaction class 4: IKKa-IkBa dissociation
R4a = d2 * IKKaIkBa
R4b = d2 * f1 * IKKaIkBaNFkB

Reaction class 5: IKKa-IkBa Catalytic dissociation
R5a = kcat * IKKaIkBa
R5b = kcat * f2 * IKKaIkBaNFkB

Reaction class 6: Degradation of IKK
R6a = kdeg * IKKn
R6b = kdeg * IKKa
R6c = kdeg * IKKi

Reaction class 7: Degradation of free IkBa proteins
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R7 = de1 * IkBa

Reaction class 8: Degradation of IkBa complex to NFkB
R8 = de3 * IkBaNFkB

Reaction class 9: Degradation of A20 proteins
R9 = de2 * A20

Reaction class 10: Degradation of IkBa mRNA
R10 = dm1 * IkBam

Reaction class 11: Degradation of A20 mRNA
R11 = dm2* A20m

Reaction class 12: Synthesis of IKKn
R12 = kprod

Reaction class 13: Inducible synthesis of IkBa mRNA
R13 = s1 * NFkBn

Reaction class 14: Inducible synthesis of A20 mRNA
R14 = s2 * NFkBn

Reaction class 15: Constitutive synthesis of IkBa mRNA
R15 = cs1

Reaction class 16: Constitutive synthesis of A20 mRNA
R16 = cs2

Reaction class 17: Translation from IkBa mRNA to IkBa proteins
R17 = t1 * IkBam
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Reaction class 18: Translation from A20 mRNA to A20 proteins
R18= t2 * A20m

Reaction class 19: Activation of IKKn to IKKa
R19= k1 * R0 * IKKn * TLR4

Reaction class 20: Inactivation of IKKa because of A20
R20 = k2 * R0* A20* IKKa

Reaction class 21: Spontaneous Inactivation of IKKn to IKKi
R21= k3 * IKKa

Reaction class 22: IkBa Import to the nucleus
R22= i1a * IkBa

Reaction class 23: IkBa export from the nucleus to cytoplasm
R23 = e1a * IkBan

Reaction class 24: IkBanNFkBn export from the nucleus to cytoplasm
R24 = e2a * IkBanNFkBn

Reaction class 25: NFkB import to the nucleus from cytoplasm
R25 = i1 * NFkB

Reaction class 26: IkBb-NFkB Association (#)
R26a = a3 * NFkB * IkBb
R26b = a3 * NFkB * IKKaIkBb
R26c = a3 * NFkBn * IkBbn

Reaction class 27: IKKa-IkBb Association (#)
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R27a = a4 * IKKa * IkBb
R27b = a4 * f3 * IKKa * IkBbNFkB

Reaction class 28: IkBb-NFkB dissociation (#)
R28a = d3 * IkBbNFkB
R28b = d3 * IKKaIkBbNFkB
R28c = d3 * IkBbnNFkBn

Reaction class 29: IKKa-IkBb dissociation (#)
R29a = d4 * IKKaIkBb
R29b = d4 * IKKaIkBbNFkB

Reaction class 30: IKKa-IkBbCatalytic dissociation (#)
R30a = kcatb * IKKaIkBa
R30b = kcatb * f2 * IKKaIkBaNFkB

Reaction class 31: Degradation of free IkBb proteins (#)
R31 = de4 * IkBb

Reaction class 32: Degradation of IkBb complex to NFkB (#)
R32 = de5 * IkBbNFkB

Reaction class 33: Degradation of NFX mRNA (#)
R33 = dm3 * NFXm

Reaction class 34: Degradation of IkBb mRNA (#)
R34 = dm4* IkBbm

Reaction class 35: Inducible synthesis of NFX mRNA (#)
R35 = s3 * NFkBn
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Reaction class 36: Inducible synthesis of IkBb mRNA (#)
R36 = s4 * NFXn

Reaction class 37: Constitutive synthesis of NFX mRNA (#)
R37 = cs3

Reaction class 38: Constitutive synthesis of IkBb mRNA (#)
R38 = cs4

Reaction class 39: Translation from NFX mRNA to NFX proteins (#)
R39 = t3 * NFXm

Reaction class 40: Translation from IkBb mRNA to IkBb proteins (#)
R40= t4 * IkBbm

Reaction class 41: NFX Import to the nucleus (#)
R41= i3 * NFX

Reaction class 42: NFX export from the nucleus to cytoplasm (#)
R42 = e3 * NFXn

Reaction class 43: IkBb Import to the nucleus (#)
R43= i1b * IkBb

Reaction class 44: IkBb export from the nucleus to cytoplasm (#)
R44 = e1b * IkBbn

Reaction class 45: IkBbnNFkBn export from the nucleus to cytoplasm (#)
R45 = e2b * IkBbnNFkBn

Reaction class 46: Degradation of NFX Proteins (#)
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R46 = de6 * NFX
(#) represents the components which are involved only in Model 2.

Table A.3 Differential equations that define the mathematical model 1 for NFkB
signaling pathway
dIKKn/dt

= R12 - R19 - R6a

dIKKa/dt

= R19 - R20 - R21- R6b - R2a - R2b + R4a + R4b + R5a + R5b

dIKKi/dt

= R20 + R21 - R6c

dIKKaIkBa/dt

= R2a - R4a - R5a –R1c + R3c

dIKKaIkBaNFkB/dt

= R1c + R2b- R3c - R4b - R5b

dNFkB/dt

= R3a + R3c - R1a- R1c + R5b + R8 - R25

dNFkBn/dt

= R3b + kv * R25 - R1b

dA20/dt

= R18 - R9 - R20

dA20m/dt

= R16 + R14 -R11

dIkBa/dt

= R3a -R1a + R4a -R2a -R22+R23/kv +R17-R7

dIkBan/dt

= R3b - R1b + kv * R22 - R23

dIkBam/dt

= R13+ R15 - R10

dIkBaNFkB/dt

= R1a - R3a - R2b +R4b + R24 / kv - R8

dIkBanNFkBn/dt

= R1b - R3b - R24
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Table A.4 Differential equations that define the mathematical model 2 for NFkB
signaling pathway
dIKKn/dt
dIKKa/dt

= R12 - R19 - R6a
= R19 - R20 - R21- R6b - R2a - R2b + R4a + R4b + R5a

+

R5b- R27a - R27b + R29a + R29b + R30a + R30b
dIKKi/dt

= R20 + R21 - R6c

dIKKaIkBa/dt

= R2a - R4a - R5a –R1c + R3c

dIKKaIkBaNFkB/dt

= R1c + R2b- R3c - R4b - R5b

dNFkB/dt

= R3a + R3c - R1a- R1c + R5b + R8 - R25 + R28a + R28b -

R26a - R26b + R30b + R32
dNFkBn/dt

= R3b + kv * R25 - R1b - R26c + R28c

dA20/dt

= R18 - R9 - R20

dA20m/dt

= R16 + R14 -R11

dIkBa/dt

= R3a -R1a + R4a -R2a -R22+R23/kv +R17-R7

dIkBan/dt

= R3b - R1b + kv * R22 - R23

dIkBam/dt

= R13+ R15 - R10

dIkBaNFkB/dt

= R1a - R3a - R2b +R4b + R24 / kv - R8

dIkBanNFkBn/dt

= R1b - R3b - R24

dIkBb/dt

= R40 -R26a -R27a + R28a + R29a - R31 -R43 + R44/kv

dIkBbNFkB/dt

= R26a - R27b - R28a + R29b - R32+ R45/kv

dIKKaIkBb/dt

= R27a - R29a - R26b - R30a + R28b

dIKKaIkBbNFkB/dt

= R26b + R27b- R28b - R29b - R30b

dIkBbm/dt

= R36+ R38 - R34

dNFX/dt

= R39 - R41 + R42/kv - R46

dNFXn/dt

= kv * R41 - R42

dNFXm/dt

= R37 + R35 - R33

dIkBbn/dt

= R43/kv - R44 - R26c + R28c

dIkBbnNFkBn/dt

= R26c - R28c - R45
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Table A.5 List of parameters and corresponding values model 1 and model 2. The values
for the reaction rate parameters correspond to the maximum likelihood values Numerical
subscripts indicate the reaction class to which the parameters correspond. Values
determined during model calibration are indicated by an asterisk (*).
Symbol

Definition

Value

Units

Refs

a1

IkBa-NFkB association rate

0.5

s-1

11,13
-1 -1

a2

IKKa-IkBa association rate

f1

The factor of NFkB on IKKa-IkBa association

kcat

KKa-IkBa catalytic dissociation rate

f2

The factor of NF-kB on IKKa-IkBa catalysis

d1

IkBa-NFkB reversible dissociation rate

μM s

*

-

11,22

s-1

*

5

-

11,22

1.25e-3

s-1

11

-1

11

0.2

d2

IKKa-IkBa reversible dissociation rate

0.5e-3

s

s1

IkBa-inducible mRNA synthesis

s-1

*

s2

A20-inducible mRNA synthesis

s-1

*

cs1

IkBa-constitutive mRNA synthesis

μM s-1

*

cs2

A20-constitutive mRNA synthesis

μM s-1

*

de1

Spontaneous, free IkBa protein degradation

0.0001

s-1

20

-1

13

de2

A20 protein degradation

0.0003

s

de3

IkBa degradation (complexed to NF-kB)

2e-5

s-1

20

dm1

IkBa mRNA degradation

0.0004

s-1

43

dm2

A20 mRNA degradation

s-1

*

t1

IkBa translation rate

s-1

13

t2

0.5

A20 translation rate

s

-1

*

-1

13

k1

IKK activation rate

0.0025

s

k2

IKK inactivation rate by A20

0.1

s-1

13

k3

IKKspontaneous inactivation rate

0.0015

s-1

13

kprod

IKKn production rate

2.5e-5

s-1

13

kdeg

IKKa, IKKn and IKKi degradation

1.25e-4

s-1

13

kv

Cytoplasmic to nuclear volume

7

-

45

i1

NF-kB nuclear import rate

0.09

s-1

11

i1a

IkBa nuclear import rate

0.0003

s-1

11
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e1a

IkBa nuclear export rate

0.0002

s-1

11

-1

*

e2a

IkBa-NFkB nuclear export rate

0.014

s

dcpa

DCPA treatment concentration

0 or 100

μM

-

0.5

s-1

11,13

μM-1 s-1

*

-

11,22

The following parameters are only in Model 2
a3

IkBb-NFkB association rate

a4

IKKa-IkBb association rate

f3

The factor of NFkB on IKKa-IkBb association

5

kcatb

KKa-IkBa catalytic dissociation rate

f4

The factor of NF-kB on IKKa-IkBb catalysis

5

-

11,22

d3

IkBb-NFkB reversible dissociation rate

1.25e-3

s-1

11

d4

IKKa-IkBb reversible dissociation rate

0.5e-3

s-1

11

s3

NFX-inducible mRNA synthesis

s-1

*

s4

IkBb -inducible mRNA synthesis

s

-1

*

cs3

NFX-constitutive mRNA synthesis

μM s-1

*

cs4

IkBb-constitutive mRNA synthesis

μM s-1

*

de4

Spontaneous, free IkBb protein degradation

0.0001

s-1

20

de5

IkBb degradation (complexed to NF-kB)

2e-5

s-1

20

dm4

IkBb mRNA degradation

0.0004

s-1

43

dm3

NFX mRNA degradation

t4

IkBb translation rate

t3

NFX translation rate

i3

NFX nuclear import rate

e3

NFX export rate from nucleus

s

-1

s

*

s-1

13

s-1

*

0.09

s-1

*

0.0003

s-1

*

0.5
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-1

*

Supplement 1: Description of biochemical reactions and converting them to ordinary
differential equations

IKKn: IKK in neutral state
The first term describes IKKn synthesis; the second one describes the depletion of IKKn
due to the TLR4 signal-induced transformation into active form IKKa, while the last one
describes the spontaneous degradation.
dIKKn / dt

=

kprod - k1 * R0 * IKKn * TLR4 - kdeg * IKKn

(1)

IKKa: IKK in active state
The first line represents the activation of IKK by TLR4 signal, the deactivation of IKK
induced by A20 and spontaneous deactivation of active IKK; The second line and the
third line reprensent spontaneous degradation of IKKa, depletion of free IKKa due to
formation of complexes of IKKaIkBa and IKKaIkBaNFkB, and concentration change of
IKKa due to dissociation of IKKaIkBa and IKKaIkBaNFkB complexes . The presence of
NFkB enhances the effecient of IKKa and IkBa interaction by a factor f1[9]. The final
line represents the concentration change due to catalysis. IKKa is still active after
catalystic phosphralation.
dIKKa/dt =

k1 * IKKn * TLR4 - k2 * R0* A20* IKKa - k3 * IKKa
- kdeg * IKKa - a2 * IKKa * IkBa - a2 * f1 * IKKa * IkBaNFkB

(2)

+ d2 * IKKaIkBa + d2 * f1 * IKKaIkBaNFkB
+ kcat * IKKaIkBa + kcat * f2 * IKKaIkBaNFkB

IKKi: inactive state of IKK
First term describes inactive IKK forming due to A20, the second describes the
concentration increase of IKKi due to IKKa spontaneous deactivation, while the third one
represents the degradation of IKKi. IKKi is assued has the same spontaneous degradation
rate as IKKn and IKKa.

dIKKi/dt

= k2 * A20* IKKa + k3 * IKKa - kdeg * IKKi

IKKaIkBa: complex of IKKa and IkBa
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(3)

The first line describes the concentration change of IKKaIkBa due to IkBa
associates ,dissociates with IKKa and catalytic by IKKa; The second line represents
association and dissociation between IKKaIkBa and NFkB.
dIKKaIkBa/dt

= a2 * IKKa * IkBa - d2 * IKKaIkBa - kcat * IKKaIkBa
– a1 * NFkB * IKKaIkBa + d1 * IKKaIkBaNFkB

(4)

IKKaIkBaNFkB: complex of IKKa, IkBa and NFkB
The first line represents the association and dissociation between IKKaIkBa and NFkB;
the second line represents the association and dissociation between IKKa and IkBaNFkB;
The final line describel the depletion of IKKaIkBaNFkB due to the catalysis process.
dIKKaIkBaNFkB/dt

= a1 * NFkB * IKKaIkBa - d1 * IKKaIkBaNFkB
+ a2 * f1 * IKKa * IkBaNFkB - d2 * f1 * IKKaIkBaNFkB (5)
- kcat * f2 * IKKaIkBaNFkB

NFkB: Free cytoplasmic NFkB
The first line describes free NFkB concentration increase due to dissociation of
IkBaNFkB and IKKaIkBaNFkB; the second line describes the decrease of free NFkB
due to association with IkBa, IKKaIkBa and shuttling into the nucleus. The final line
represents the concentration increase due to IKKa catalytic degrading IkBa and
spontonous degradation of bound IkBa. The factor f2 represents the effect of the presence
of NFkB on IKKa phosphralating IkBa[9].

dNFkB/dt

= d1 * IkBaNFkB + d1 * IKKaIkBaNFkB
- a1 * NFkB * IkBa - a1 * NFkB * IKKaIkBa - i1 * NFkB (6)
+ kcat * f2 * IKKaIkBaNFkB + de3 * IkBaNFkB

NFkBn: Free NFkB in the nucleus
First term and second represent free NFkBn changes due to dissociation and association
between IkBa and NFkB in the nucleus; and the last term reprensents that NFkB imports
to the nucleus from the cytoplasm. Because of the volume of cytoplasm is larger than the
nucleus, kv = the volume of the cytoplasm / the volume of the nucleus, the concentration
change due to importion is kv times of that in the cytoplasm.
dNFkBn/dt

= d1 * IkBanNFkBn - a1 * NFkBn * IkBan + kv * i1 * NFkB (7)

A20: A20 protein in the cytoplasm
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First term discripes A20 protein production rate due to the translation from A20 mRNA;
the second term represent degradation of A20 protein; and the final term represents that
free A20 decreases because of inhibiting IKK activity. We assume that TLR4
consductive signaling is required to activate A20.
dA20/dt

= t2 * A20m - de2 * A20 - k2 * TLR4* A20* IKKa

(8)

A20m: A20 messenger RNA
We seperate the synthesis of A20 mRNA to two parts. One is constuctive and the other is
first-order dependent on free NFkB concentration in the nucleus. The last term represents
first order degradation of A20 mRNA.
dA20m/dt

= cs2 + s2 * NFkBn - dm2* A20m

(9)

IkBa: Free IkBa in the cytoplasm
The first and second lines represent the concentration change of free IkBa due to the
dissociation and association obetween IkBa and NFkB, and between IKKa and IkBa; the
last line represents free IkBa protein importing to, exporting from the neucleus,
translation form IkBa mRNA and spontanous degradation.
dIkBa/dt

= d1 * IkBaNFkB - a1 * NFkB * IkBa
+ d2 * IKKaIkBa - a2 * IKKa * IkBa

(10)

- i1a * IkBa + e1a * IkBan /kv + t1 * IkBam - de1 * IkBa

IkBan: Free IkBa in the nucleus
First line represents IkBa concentration change due to the dissociation and association
between IkBa and NFkB; the sencond line represents IkBa concentration change caused
by free IkBa shuttling between the cytoplasm and the nucleus.
dIkBan/dt

= d1 * IkBanNFkBn - a1 * NFkBn * IkBan

(11)

+ kv * i1a * IkBa - e1a * IkBan
IkBam: IkBa messenger RNA
We seperate the synthesis of IkBa mRNA to two parts. One is constuctive and the other is
first-order dependent on free NFkB concentration in the nucleus. The last term represents
first order degradation of IkBa mRNA.
dIkBam/dt

=

cs1 + s1 * NFkBn - dm1 * IkBam
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(12)

IkBaNFkB: cytoplasmic IkBaNFkB complex
First line represents the concentration change of IkBaNFkB due to the association and
dissociation between IkBa and NFkB; second line describes the the concentration change
of IkBaNFkB due to the association and dissociation between IKKa and IkBa NFkB.
NFkB increases the association rate of IKKa and IkBa according experimental data[9].
Based on the motif-motif interaction principle, the affinity of IKKa and IkBa doesn’t
change, so the dissociation between them also is increased by f1 times. The final line
represents the exporting of IkBaNFkB from the nucleus and the degradation of
IkBaNFkB.
dIkBaNFkB/dt

= a1 * NFkB * IkBa - d1 * IkBaNFkB
- a2 * f1 * IKKa * IkBaNFkB + d2 * f1 * IKKaIkBaNFkB (13)
+ e2a * IkBanNFkBn / kv - de3 * IkBaNFkB

IkBanNFkBn: IkBaNFkB complex in the nucleus
First line represents the concentration change due to the association and dissociation
between NFkBn and IkBan; the second line represents the exporting of IkBan NFkBn
from the nucleus.
dIkBanNFkBn/dt

= a1 * NFkBn * IkBan - d1 * IkBanNFkBn
- e2a * IkBanNFkBn

(14)

The second model will add IkBb into the signaling network. IkBb can reacte with IKKa
and NFkB in the cytoplasm and can also bind with NFkB in the nucleus. The different of
IkBb and IkBa is that IkBb is induced by an unknow nuclear factor X which is induced
by NFkB. 10 more equations are added, described as below. However, the differential
equations of IKK, NFkB and NFkBn will be changed due to their interaction with IkBb.
IKKa: IKK in active state
The first line represents the activation of IKK by TLR4 signal, the deactivation of IKK
induced by A20 and spontaneous deactivation of active IKK; The second line and the
third line reprensent spontaneous degradation of IKKa, depletion of free IKKa due to
formation of complexes of IKKaIkBa and IKKaIkBaNFkB, and concentration change of
IKKa due to dissociation of IKKaIkBa and IKKaIkBaNFkB complexes . The presence of
NFkB enhances the effecient of IKKa and IkBa interaction by a factor f1[9]. The fourth
line represents the concentration change due to catalysis. IKKa is still active after
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catalystic phosphralation. IKKa can also phosprolate IkBb. The last three lines represents
the association between IKKa and IkBb, IKKa and IkBbNFkB, and catalysis of
IKKaIkBb and IKKaIkBbNFkB. Factors f3 and f4 represent the effects of NFkB on IKKa
associating and catalysizing IkBb.

dIKKa/dt =

k1 * IKKn * TLR4 - k2 * R0* A20* IKKa - k3 * IKKa
- kdeg * IKKa - a2 * IKKa * IkBa - a2 * f1 * IKKa * IkBaNFkB

(2*)

+ d2 * IKKaIkBa + d2 * f1 * IKKaIkBaNFkB
+ kcat * IKKaIkBa + kcat * f2 * IKKaIkBaNFkB
- a4 * IKKa * IkBb - a4 * f3 * IKKa * IkBbNFkB
+ d4 * IKKaIkBb + d4 * f3* IKKaIkBbNFkB
+ kcat * IKKaIkBb + kcatb * f4 * IKKaIkBbNFkB

NFkB: Free cytoplasmic NFkB
The first line describes free NFkB concentration increase due to dissociation of
IkBaNFkB and IKKaIkBaNFkB; the second line describes the decrease of free NFkB
due to association with IkBa, IKKaIkBa and shuttling into the nucleus. The Third line
represents the concentration increase due to IKKa catalytic degrading IkBa and
spontonous degradation of bound IkBa. The factor f2 represents the effect of the presence
of NFkB on IKKa phosphralating IkBa[9]. The last three lines represent the concentration
of NFkB due to its dissociation and association with IkBb, IKKaIkBb, and degradation of
IkBb due to IKKa phospralation and spontanous degradation.

dNFkB/dt

= d1 * IkBaNFkB + d1 * IKKaIkBaNFkB
- a1 * NFkB * IkBa - a1 * NFkB * IKKaIkBa - i1 * NFkB (6*)
+ kcat * f2 * IKKaIkBaNFkB + de3 * IkBaNFkB
+ d3 * IkBbNFkB + d3 * IKKaIkBbNFkB
- a3 * NFkB * IkBb – a3 * NFkB * IKKaIkBb
+ kcatb * f4 * IKKaIkBbNFkB + de5 * IkBbNFkB
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NFkBn: Free NFkB in the nucleus
First term and second represent free NFkBn changes due to dissociation and association
between IkBa and NFkB in the nucleus; and the third term reprensents that NFkB imports
to the nucleus from the cytoplasm. Because of the volume of cytoplasm is larger than the
nucleus, kv = the volume of the cytoplasm / the volume of the nucleus, the concentration
change due to importion is kv times of that in the cytoplasm. The last line represents the
dissociation and association between NFkB and IkBb in the nucleus.
dNFkBn/dt

=

d1 * IkBanNFkBn - a1 * NFkBn * IkBan + kv * i1 * NFkB
+ d3 * IkBbnNFkBn – a3 * NFkBn * IkBbn

(7*)

IkBb: Free IkBb in the cytoplasm
The first and second lines represent the concentration change of free IkBb due to the
dissociation and association obetween IkBb and NFkB, and between IKKa and IkBb; the
last line represents free IkBb protein importing to, exporting from the neucleus,
translation form IkBb mRNA and spontanous degradation.
dIkBb/dt

= d3 * IkBbNFkB – a3 * NFkB * IkBb
+ d4 * IKKaIkBb – a4 * IKKa * IkBb

(15)

- i1b * IkBb + e1b * IkBbn /kv + t4 * IkBbm – de4 * IkBb

IkBbNFkB: cytoplasmic IkBbNFkB complex
First line represents the concentration change of IkBbNFkB due to the association and
dissociation between IkBb and NFkB; second line describes the the concentration change
of IkBbNFkB due to the association and dissociation between IKKa and IkBb NFkB.
NFkB increases the association rate of IKKa and IkBb according experimental data[9].
Based on the motif-motif interaction principle, the affinity of IKKa and IkBb doesn’t
change, so the dissociation between them also is increased by f3 times. The final line
represents the exporting of IkBbNFkB from the nucleus and the degradation of
IkBbNFkB.

dIkBaNFkB/dt

= a3 * NFkB * IkBa – d3 * IkBbNFkB
- a4 * f3 * IKKa * IkBbNFkB + d4 * f3 * IKKaIkBbNFkB
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+ e2b * IkBbnNFkBn / kv – de5 * IkBbNFkB

(16)

IKKaIkBb: complex of IKKa and IkBb
The first line describes the concentration change of IKKaIkBb due to IkBb
associates ,dissociates with IKKa and catalytic by IKKa; The second line represents
association and dissociation between IKKaIkBb and NFkB.
dIKKaIkBa/dt

= a4 * IKKa * IkBb – d4 * IKKaIkBb - kcatb * IKKaIkBb
– a3 * NFkB * IKKaIkBb + d3 * IKKaIkBbNFkB

(17)

IKKaIkBbNFkB: complex of IKKa, IkBb and NFkB
The first line represents the association and dissociation between IKKaIkBb and NFkB;
the second line represents the association and dissociation between IKKa and IkBbNFkB;
The final line describel the depletion of IKKaIkBbNFkB due to the catalysis process.
dIKKaIkBbNFkB/dt

= a3 * NFkB * IKKaIkBb - d3 * IKKaIkBbNFkB
+ a4 * f3 * IKKa * IkBbNFkB – d4 * f3 * IKKaIkBbNFkB (18)
- kcatb * f4 * IKKaIkBbNFkB

IkBbm: IkBb messenger RNA
We seperate the synthesis of IkBb mRNA to two parts. One is constuctive and the other
is first-order dependent on free NFkB concentration in the nucleus. The last term
represents first order degradation of IkBb mRNA.
dIkBbm/dt

=

cs4 + s4 * NFkBn – dm4 * IkBbm

(19)

NFX: unknown transcription factor
There is a time delay for IkBb transcription following NFkB activity.[23] This time
delay may be caused by an intermidate transcription factor, like foxj1[24] . But we don’t
know much about this intermidate transcription factor. In the following equation, the first
term represents the production of NFX translation from RNA, and the second and the
third terms describe the concentration change of NFX due to shuttling between the
cytoplasm and the nucleus; the final term represents the degradation of NFX.
dNFX/dt

= t3 * NFXm - i3 * NFX + e3 * NFXn /kv - de6 * NFX

(20)

NFXn: NFX in the nucleus
First term represents NFX imports to the nucleus while the second term represents its
exporting from the nucleus.
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dNFXn/dt

= kv * i3 * NFX - e3 * NFXn

(21)

NFXm: NFX messenger RNA
We assumethat NFX is produced by two parts, one is constudctive synthesis rate cs3, and
another part is induced by NFkB. The first term represents the constudctive synthesis of
NFX mRNA and the second represents the inducible synthesis, while the final one
represnts the degradation of NFX mRNA.
dNFXm/dt

= cs3 + s3 * NFkBn - dm3 * NFXm

(22)

IkBbn: Free IkBb in the nucleus
First line represents IkBb concentration change due to the dissociation and association
between IkBb and NFkB; the sencond line represents IkBb concentration change caused
by free IkBb shuttling between the cytoplasm and the nucleus.
dIkBbn/dt

= d3 * IkBbnNFkBn – a3 * NFkBn * IkBban

(23)

+ kv * i1b * IkBb - e1b * IkBbn
IkBbnNFkBn: IkBbNFkB complex in the nucleus
First line represents the concentration change due to the association and dissociation
between NFkBn and IkBan; the second line represents the exporting of IkBbnNFkBn
from the nucleus.
dIkBbnNFkBn/dt

= a3 * NFkBn * IkBbn – d3 * IkBbnNFkBn
- e2b * IkBbnNFkBn
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(24)

Supplement 2: Mathatical models coded in Matlab
% calc_Yhat_nfkb_01.m

function Y_hat = calc_Yhat_nfkb_01(k, X_pred);

%Dimension declarations:
n_diffeqn = 14;
n_algeb =0;
n_tot

= n_diffeqn + n_algeb;

id

= ones(n_diffeqn,1);

id(n_diffeqn+1:n_tot) = zeros(n_algeb,1);

%Initial conditions:
[y0, data] = loadParams01(k, n_tot);
t0

= 0;

% set up options
%
options = CVodeSetOptions('RelTol',1.e-6,'AbsTol',1.e-6,...
'NonlinearSolver','Newton','MaxNumSteps',6000);
CVodeMalloc(@nfkb_core01,t0,y0,options,data);
tp0 = X_pred(1,1)-60*10;
[status,t,y] = CVode(tp0,'Normal');
if (status == 0)
yp0 = y;
else
yp0 = eps.*ones(n_tot,1);
end;
iout = 1;
Y

= zeros(1,n_tot);

Y(1,:) = yp0';
nout

= size(X_pred,1);
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while iout < nout
% update output time
tout = X_pred(iout+1);
[status,t,y] = CVode(tout,'Normal');
if (status == 0)
yout = y;
else
yout = eps.*ones(n_tot,1);
end;
Y = [Y; yout'];
iout = iout+1;
end
CVodeFree;
%-------------------------------------------------------------------% post-processing to compare to experimental data- free nuclear NFkB
%--------------------------------------------------------------------

%free nuclear NFkB
Free_NFkBn = zeros(size(Y,1),1);
Free_NFkBn = Y(:,7);
detect = yp0(7);
detect2= yp0(4)+yp0(5)+yp0(10)+yp0(13);
Yhat1 = Free_NFkBn ./ detect;
% total cytoplasmic IkB protein and complex
TotalIkB = zeros(size(Y,1),1);
TotalIkB = Y(:,4)+ Y(:,5)+ Y(:,10) + Y(:,13);
Yhat2 = TotalIkB./ detect2;
%extract response predictions
Y_hat = [Yhat1 Yhat2];

return;
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function[dydt, FLAG, NEW_DATA]=nfkb_core01(t,y_nfkb,data)
%dydt=zeros(size(y_nfkb));
%
%unpack initial concentrations
%
params
tstart

= data.params;
= data.tstart;

IKKn

= y_nfkb(1); % Free unactivated cytoplasmic IKK protein

IKKa

= y_nfkb(2); % Free activated cytoplasmic IKK protein

IKKi

= y_nfkb(3); % Free deactivated cytoplasmic IKK protein

IKKaIkBa

= y_nfkb(4); % Cytoplasmic IKKa-IkBa complexes

IKKaIkBaNFkB = y_nfkb(5); % Cytoplasmic IKKa-IkBa-NFkB protein
NFkB

= y_nfkb(6); % Free cytoplasmic NF-kB protein

NFkBn

= y_nfkb(7); % Free nuclear NF-kB protein

A20

= y_nfkb(8); % Cytoplasmic A20 protein

A20m

= y_nfkb(9); % A20 mRNA

IkBa

= y_nfkb(10); % Free cytoplasmic IkBa protein

IkBan

= y_nfkb(11); % Free nuclear IkBa protein

IkBam

= y_nfkb(12); % IkBa m RNA

IkBaNFkB

= y_nfkb(13); % Cytoplasmic IkBa-NFkB complexes

IkBanNFkBn = y_nfkb(14); % Nuclear IkBa-NFkB complexes
%
%unpack times
%
start1 = tstart(1,1);
start2 = tstart(1,2);
start3 = tstart(1,3);
%
%==============================================================
% Phase specific alterations to parameters
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%==============================================================
%unpack parameters
%
a1 = 10^params(1,1); %0.5 % microM-1 sec- IKBa2NFkB association Hoffmann et al.
a2 = 10^params(2,1); % mM-1 sec-1 IKKa IkBa association fitting
f1 = 10^params(3,1); %0.2 the factor of NFkB on IKKa-IkBa association Hoffmann et al.
kcat= 10^params(4,1); % sec-1 IKKajIkBa catalysis fitting
f2 = 10^params(5,1); %5% the factor of NFkB on IKKa-IkBa catalysis Hoffmann et al
d1 = 10^params(6,1); %IkBa-NFkB reversible dissociation rate

1.25e-3

s-1

0.5e-3 s-1

(2)

(2)
d2 = 10^params(7,1); %IKK-IkBa reversible dissociation rate

s1 = 10^params(8,1); % 5.0e7 % sec-1 IkBa-inducible mRNA synthesis fitting
cs1 = 10^params(9,1); % 0.0 % mM sec-1 IkBa-constitutive mRNA synthesis
Assumption
dm1 = 10^params(10,1); % 0.0004 % sec-1 IkBa mRNA degradation Fitted, Blattner et al.
t1 = 10^params(11,1); % 0.5 % sec-1 IkBa translation rate Fitted lipniak 2004
de1 = 10^params(12,1); % 0.0001 % sec-1 Spontaneous, free IkBa protein degradation
Pando and Verma (2000)
de3 = 10^params(13,1); % 0.00002 % sec-1 IkBa degradation (complexed to NF-kB)
Pando and Verma (2000)
s2 = 10^params(14,1); % sec-1 A20-inducible mRNA synthesis fitting
cs2 = 10^params(15,1); % 0.0 % mM sec-1 A20-constitutive mRNA synthesis
Assumption
dm2 = 10^params(16,1); % sec-1 A20 mRNA degradation fitting
t2 = 10^params(17,1); % 0.5 % sec-1 A20 translation rate fitting
de2 = 10^params(18,1); % 0.0003 % sec-1 A20 protein degradation Fitted
k1 = 10^params(19,1); % 0.0025 % sec-1 IKK activation rate caused by TNF Fitted
k2 = 10^params(20,1); % 0.1 % sec-1 IKK inactivation rate caused by A20 Fitted
k3 = 10^params(21,1); % 0.0015 % sec-1 IKK spontaneous inactivation rate Fitted
kprod = 10^params(22,1); % 0.000025 % mM sec-1 IKKn production rate Fitted
kdeg = 10^params(23,1); % 0.000125 % sec-1 IKKa, IKKn and IKKi degradation Fitted
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%NF 0:06 V mM V Total amount of free and complexed NF-kB
Assumption, Carlotti
kv = 10^params(24,1); % 5 % Cytoplasmic to nuclear volume Assumption
i1 = 10^params(25,1); % 0.0025 % sec-1 NF-kB nuclear import Fitted
i1a = 10^params(26,1); % 0.001 % sec-1 IkBa nuclear import Fitted
e1a = 10^params(27,1); % 0.0005 % sec-1 IkBa nuclear export Assumption
e2a = 10^params(28,1); % 0.01 % sec-1 (IkBajNF-kBÞ nuclear export Fitted
kd1 = 10^params(29,1); % 0.1 % mM Dissociation constant for NF-kB to kB1 sites
kd2 = 10^params(30,1); % 0.1 % mM Dissociation constant for NF-kB to kB2 sites
inhibited by DCPA
alpha1 = 10^params(31,1);% effect of DCPA on activation of IKK
alpha2 = 10^params(32,1);% effect of DCPA on inducible production of IkBat
dcpa = 10^params(33,1); %DCPA concentration
%
% Rate equations
%
R0 =1.0 * (erf(2*(t-start2))-erf(2*(t-start3)));
R0a=dcpa * (erf(2*(t-start2))-erf(2*(t-start3)));
DCPA = R0a;
TLR4 = 1;
%Reaction class 1: IkBa-NFkB Association
R1a = a1 * NFkB * IkBa;
R1b = a1 * NFkBn * IkBan;
R1c = a1 * NFkB * IKKaIkBa;

%Reaction class 2: IKKa-IkBa Association
R2a = a2 * IKKa * IkBa;
R2b = a2 * f1 * IKKa * IkBaNFkB;

%Reaction class 3: IkBa-NFkB dissociation
R3a = d1 * IkBaNFkB;
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R3b = d1 * IkBanNFkBn;
R3c = d1 * IKKaIkBaNFkB;

%Reaction class 4: IKKa-IkBa dissociation
R4a = d2 * IKKaIkBa;
R4b = d2 * f1 * IKKaIkBaNFkB;

%Reaction class 5: IKKa-IkBa Catalytic dissociation
R5a = kcat * IKKaIkBa;%* (1 + alpha1*DCPA/(DCPA+kd1));
R5b = kcat * f2 * IKKaIkBaNFkB;%* (1 + alpha1*DCPA/(DCPA+kd1));

%Reaction class 6: Degradation of IKK
R6a = kdeg * IKKn;
R6b = kdeg * IKKa;
R6c = kdeg * IKKi;

%Reaction class 7: Degradation of free IkBa proteins
R7 = de1 * IkBa;

%Reaction class 8: Degradation of IkBa complex to NFkB
R8 = de3 * IkBaNFkB;

%Reaction class 9: Degradation of A20 proteins
R9 = de2 * A20;

%Reaction class 10: Degradation of IkBa mRNA
R10 = dm1 * IkBam;

%Reaction class 11: Degradation of A20 mRNA
R11 = dm2* A20m;
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%Reaction class 12: Synthesis of IKKn
R12 = kprod;

%Reaction class 13: Inducible synthesis of IkBa mRNA
R13 = s1 * NFkBn * (1 - alpha2 * DCPA / ( DCPA+kd2 ));

%Reaction class 14: Inducible synthesis of A20 mRNA
R14 = s2 * NFkBn * (1 - alpha2 * DCPA / ( DCPA+kd2 ));

%Reaction class 15: Constitutive synthesis of IkBa mRNA
R15 = cs1;

%Reaction class 16: Constitutive synthesis of A20 mRNA
R16 = cs2;

%Reaction class 17: Translation from IkBa mRNA to IkBa proteins
R17 = t1 * IkBam;

%Reaction class 18: Translation from A20 mRNA to A20 proteins
R18= t2 * A20m;

%Reaction class 19: Activation of IKKn to IKKa
R19= k1 * R0 * IKKn * TLR4 * (1 + alpha1*DCPA/(DCPA+kd1));

%Reaction class 20: Inactivation of IKKa because of A20
R20 = k2 * R0* A20* IKKa;

%Reaction class 21: Spontaneous Inactivation of IKKa to IKKi
R21= k3 * IKKa;

%Reaction class 22: IkBa Import to the nucleus
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R22= i1a * IkBa;

%Reaction class 23: IkBa export from the nucleus to cytoplasm
R23 = e1a * IkBan;

%Reaction class 24: IkBanNFkBn export from the nucleus to cytoplasm
R24 = e2a * IkBanNFkBn;

%Reaction class 25: NFkB import to the nucleus from cytoplasm
R25 = i1 * NFkB * (1 + alpha2*DCPA/(DCPA+kd1));

%Differential equations that define the mathematical model for NFkB signaling pathway.

dydt(1) = R12 - R19 - R6a;

% IKKn

dydt(2) = R19 - R20 - R21- R6b - R2a - R2b + R4a + R4b + R5a + R5b; %IKKa
dydt(3) = R20 + R21 - R6c;

%IKKi

dydt(4) = R2a - R4a - R5a - R1c + R3c;

%IKKaIkBa/dt

dydt(5) = R1c + R2b- R3c - R4b - R5b;

%IKKaIkBaNFkB/dt

dydt(6) = R3a + R3c - R1a- R1c + R5b + R8 - R25;
dydt(7) = R3b + kv * R25 - R1b;

%NFkB/dt

%NFkBn/dt

dydt(8) = R18 - R9 - R20;

%dA20/dt

dydt(9) = R16 + R14 -R11;

%dA20m/dt

dydt(10) = R3a -R1a + R4a -R2a -R22+R23/kv +R17-R7;
dydt(11) = R3b - R1b + kv * R22 - R23;

%dIkBa/dt

%dIkBan/dt

dydt(12) = R13+ R15 - R10;

%dIkBam/dt

dydt(13) = R1a - R3a - R2b +R4b + R24 / kv - R8;
dydt(14) = R1b - R3b - R24;

%dIkBaNFkB/dt

%dIkBanNFkBn/dt

FLAG = 0;
NEW_DATA = [];
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return;
function [y0, data] = loadParams01(k, n_tot)

% Initial conditions:
y0

= zeros(n_tot,1);

y0(1,1) = 0.02;

% mico M IKKn

%y0(10,1) = 0.06;

% Rice and Ernst(1993)

y0(13,1) = 0.06;

% mico M IkBa-NFkB cheong 2006

%-----------------------------% PARAMETERS
%------------------------------

params

= zeros(33,1);

params(1,1) = log10(0.5 );

% 0.5 a1 microM-1 sec-1 IkBa-NFkB association

Hoffmann et al. (2002)
params(2,1) = log10(0.0225);

% a2 microM-1 sec-1 IKKa-IkBa association

Assumption
params(3,1) = log10(7);

%5 f1 the factor of NFkB on IKKa-IkBa association

Hoffmann et al.
params(4,1) = log10(0.00407);
params(5,1) = log10(5) ;

% kcat % sec-1 IKKajIkBa catalysis fitting
%f2% the factor of NFkB on IKKa-IkBa catalysis

Hoffmann et al
params(6,1) = log10(0.0005);
1.25e-3

s-1

(2)

params(7,1) = log10(1.25e-3);
dissociation rate

0.5e-3 s-1

params(8,1) = k(1,1) ;

%d1 %IkBa-NFkB reversible dissociation rate

% d2 = 10^params(7,1); %IKK-IkBa reversible
(2)

% s1 = 10^params(8,1); % 5.0e7 % sec-1 IkBa-inducible

mRNA synthesis fitting
params(9,1) = log10(1.0256e-11); % cs1 = 10^params(9,1); % 0.0 % mM sec-1 IkBaconstitutive mRNA synthesis Assumption
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params(10,1) = log10(0.0004); % dm1 = 10^params(10,1); % 0.0004 % sec-1 IkBa
mRNA degradation Fitted, Blattner et al.
params(11,1) = k(2,1);

% t1 = 10^params(11,1); % 0.5 % sec-1 IkBa translation rate

Fitted lipniak 2004
params(12,1) = log10(0.000113); % de1 = 10^params(12,1); % 0.0001 % sec-1
Spontaneous, free IkBa protein degradation Pando and Verma (2000)
params(13,1) = log10(0.0000225); % de3 = 10^params(13,1); % 0.00002 % sec-1 IkBa
degradation (complexed to NF-kB) Pando and Verma (2000)
params(14,1) = k(3,1);

% s2 = 10^params(14,1); % sec-1 A20-inducible mRNA

synthesis fitting
params(15,1) = k(4,1); % cs2 = 10^params(15,1); % 0.0 % mM sec-1 A20-constitutive
mRNA synthesis Assumption
params(16,1) = k(5,1);

%dm2 = 10^params(16,1); % sec-1 A20 mRNA

degradation fitting
params(17,1) = k(6,1);

%t2 = 10^params(17,1); % 0.5 % sec-1 A20 translation rate

fitting
params(18,1) = log10(0.0003); % de2 = 10^params(18,1); % 0.0003 % sec-1 A20
protein degradation Fitted
params(19,1) = k(7,1);

% k1 sec-1

0.0025 IKK activation rate caused by TNF

Fitted
params(20,1) = k(8,1);

% k2 sec-1

params(21,1) = log10(3.2374e-10);

IKK inactivation rate caused by A20 Fitted
% k3 sec-1

IKK spontaneous inactivation rate

Fitted
params(22,1) = k(9,1) ;

%kprod IKKn synthesis rate

params(23,1) = k(10,1);

% kdeg sec-1 IKKa, IKKn and IKKi degradation Fitted

params(24,1) = log10(7);

% kv 7

Cytoplasmic to nuclear volume Assumption

7 Cheong 2006, 5 Lipniacki 2004, 2006
params(25,1) = k(12,1);%log10(0.0013); % i1 sec-1

NF-kB nuclear import Fitted

%0.0025 Lipniacki 2004, 2006; 0.09 Werner 2005
params(26,1) = k(11,1)+log10(2); % i1a sec-1 IkBa nuclear import Fitted
%0.001 Lipniacki 2004, 0.002 Lipniacki 2006, 0.0003 Werner 2005
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params(27,1) = k(11,1); % e1a sec-1 IkBa nuclear export Assumption
%0.0005 Lipniacki 2004, 0.005 Lipniacki 2006, 0.0002 Werner 2005
params(28,1) = k(13,1); % e2a sec-1 IkBa-NF-kB nuclear export Fitted
%0.01 Lipniacki 2004, 0.05 Lipniacki 2006, 0.014 Werner 2005

params(29,1) = log10(5);

% kd1 mM

Half-maximum DCPA concentration

params(30,1) = log10(5);

% kd2 mM

Half-maximum DCPA concentration

params(31,1) = log10(0.48);

% alpha1

Effect of DCPA on activating IKK

params(32,1) = log10(0.013);

% alpha2 effect of DCPA on NFkB inducible

producing IkBa mRNA
params(33,1) = log10(1.0e-20 ); %DCPA concentration is 100 uM

if size(params,1) == 1
params = params';

% convert K to a column vector instead of a row vector

end;

% start and stop times of LPS bolus in nfkb_core01 file
tstart = [0 2000*60 6*60*60+2000*60];
%pack parameters into data struct
data.params = params;
data.tstart = tstart;

return;
function [kin] = InitParams01()
% Load paramaters - mean values from MCMC run
kin = zeros(13,1);

kin(1,1) = log10(4.2615e-5); % s1 = 10^params(8,1); % 5.0e7 % sec-1 IkBa-inducible
mRNA synthesis fitting
%kin(2,1) = log10(1.0256e-11) ; % cs1 = 10^params(9,1); % 0.0 % mM sec-1 IkBaconstitutive mRNA synthesis Assumption
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kin(2,1) = log10(0.6592); % t1 IkBa translation rate
kin(3,1) = log10(0.0967 );

% s2 = 10^params(14,1); % sec-1 A20-inducible mRNA

synthesis fitting
kin(4,1) = log10(8.634e-7); % cs2 = 10^params(15,1); % 0.0 % mM sec-1 A20constitutive mRNA synthesis Assumption
kin(5,1) = log10(0.0716); % dm2 = 10^params(16,1); % sec-1 A20 mRNA
degradation fitting
kin(6,1) = log10(0.4138); %t2 = 10^params(17,1); % 0.5 % sec-1 A20 translation rate
fitting
kin(7,1) = log10(0.0016); % k1 sec-1

0.0025 IKK activation rate caused by TNF

Fitted
kin(8,1) = log10(0.2462);

% k2 sec-1

IKK inactivation rate caused by A20 Fitted

%kin(10,1) = log10(3.2374e-10); % k3 sec-1

IKK spontaneous inactivation rate

Fitted
kin(9,1) = log10(4.707e-4); % kprod microM sec-1 IKKn production rate Fitted
kin(10,1) = log10(0.0031); % kdeg sec-1 IKKa, IKKn and IKKi degradation Fitted
kin(11,1) = log10(1.3858e-4); % e1a sec-1

IkBa nuclear export Assumption

%0.0005 Lipniacki 2004, 0.005 Lipniacki 2006, 0.0002 Werner 2005
kin(12,1) = log10(4.3958e-4); % i1 sec-1

NF-kB nuclear import Fitted

%0.0025 Lipniacki 2004, 2006; 0.09 Werner 2005
kin(13,1) = log10(0.002); % e2a sec-1

IkBa-NF-kB nuclear export Fitted

if size(kin,1) == 1
kin = kin'; % convert k to a column vector instead of a row vector
end;

return;
function [data] = data_nfkb01
% Populate Propanil data array
% Initialization
data=struct('ppn',{},'tdata',{},'values',{});
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% Load data arrays
%tdata = [[0];[5];[7];[10];[11];[12];[15];[13];[16];[19];[22];[304.5];[28];[31];[33];[35];[39];[45-4.5];[42];[43];[45];[47];[49];[51];[53];[604.5];[57];[59];[61];[63];[65];[67];[69];[75-4.5];[73];[75];[77];[79];[81];[83];[85];[904.5];[87];[89];[91];[93];[95];[97];[99];[1054.5];[103];[105];[107];[109];[111];[113];[115];[1204.5];[116];[117];[119];[121];[123];[125];[127];[130];[132];[134];[136];[138];[140];[142]
;[1504.5];[147];[149];[152];[155];[157];[159];[161];[163];[165];[167];[169];[171];[173];[175]
;[1804.5];[177];[179];[182];[185];[187];[189];[192];[195];[197];[199];[201];[203];[204];[205]
;[210-4.5];[207];[210];[215];[220];[225];[230];[233];[2404.5];[237];[240];[245];[250];[255];[260];[263];[2704.5];[267];[270];[275];[280];[285];[290];[293];[3004.5];[297];[300];[305];[310];[315];[320];[325];[3304.5];[327];[330];[335];[340];[345];[350];[355];[360-4.5]];
%Experiment 1
%data(1).ppn = 0;
%data(1).tdata = tdata .*60+ 2000*60;
%data(1).values = [[1 1];[1.47 1];[3 0];[6.51 1];[7.5 0];[10 0];[9.71 1];[13 0];[19 0];[22
0];[16 0];[13.22 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[6.43 1];[42 0];[43 0];[45 0];[47
0];[49 0];[51 0];[53 0];[5.64 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69 0];[5.27
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[10.08 1];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[9.28 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[6.95
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[5.67 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[7.31 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75
0];[77 0];[79 0];[81 0];[83 0];[85 0];[7.51 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[6.88 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[6.77 0];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[7.84 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[7.47 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[8.23 0]];
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% total cytoplasmic IkB
%data(1).values = [[1 1];[1.47 1];[3 0];[6.51 1];[7.5 0];[10 0];[9.71 1];[13 0];[19 0];[22
0];[16 0];[13.22 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[6.43 1];[42 0];[43 0];[45 0];[47
0];[49 0];[51 0];[53 0];[5.64 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69 0];[5.27
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[10.08 1];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[9.28 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[6.95
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[5.67 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[7.31 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75
0];[77 0];[79 0];[81 0];[83 0];[85 0];[7.51 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[6.88 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[6.77 1];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[7.84 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[7.47 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[8.23 1]];
% Cyto. IkBa
%data(3).ppn = 0;
%data(3).tdata = tdata .*60+ 2000*60;
%data(3).values = [[1 1];[0.97 1];[3 0];[0.567 1];[7.5 0];[10 0];[0.255 1];[13 0];[19 0];[22
0];[16 0];[0.482 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[0.950 1];[42 0];[43 0];[45 0];[47
0];[49 0];[51 0];[53 0];[0.764 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69 0];[0.794
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.769 1];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.592 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.587
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[0.663 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[0.608 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.733 0];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.688 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.849
0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.693 0];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.869 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.608 0]];
%data(3).values = [[1 1];[0.97 1];[3 0];[0.567 1];[7.5 0];[10 0];[0.255 1];[13 0];[19 0];[22
0];[16 0];[0.482 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[0.950 1];[42 0];[43 0];[45 0];[47
0];[49 0];[51 0];[53 0];[0.764 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69 0];[0.794
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1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.769 1];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.592 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.587
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[0.663 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[0.608 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.733 1];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.688 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.849
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.693 1];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.869 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.608 1]];

%Experiment 2
%data(2).ppn = 100;
%data(2).tdata = tdata.*60+2000*60;
%data(2).values = [[1 1];[1.41 1];[3 0];[5.60 1];[7.5 0];[10 0];[11.11 1];[13 0];[19 0];[22
0];[16 0];[10.77 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[6.01 1];[42 0];[43 0];[45 0];[47
0];[49 0];[51 0];[53 0];[6.21 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69 0];[7.93
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[9.29 1];[73 0];[75 0];[77 0];[79 0];[81
0];[83 0];[85 0];[7.49 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[5.72 1];[73
0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[5.75 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81
0];[83 0];[85 0];[8.80 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[7.58 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[6.84 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[6.57 0];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[8.18 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[7.78 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[9.20 0]];
%data(2).values = [[1 1];[1.41 1];[3 0];[5.60 1];[7.5 0];[10 0];[11.11 1];[13 0];[19 0];[22
0];[16 0];[10.77 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[6.01 1];[42 0];[43 0];[45 0];[47
0];[49 0];[51 0];[53 0];[6.21 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69 0];[7.93
1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[9.29 1];[73 0];[75 0];[77 0];[79 0];[81
0];[83 0];[85 0];[7.49 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[5.72 1];[73
0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
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0];[5.75 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81
0];[83 0];[85 0];[8.80 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[7.58 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[6.84 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[6.57 1];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[8.18 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[7.78 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[9.20 1]];
%Cyto.IkBa

% total cytoplasmic IkB
%data(4).ppn = 100;
%data(4).tdata = tdata .*60+ 2000*60;
%data(4).values = [[0.949 1];[0.864 1];[3 0];[0.376 1];[7.5 0];[10 0];[0.235 1];[13 0];[19
0];[22 0];[16 0];[0.430 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[0.928 1];[42 0];[43 0];[45
0];[47 0];[49 0];[51 0];[53 0];[0.726 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69
0];[0.897 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.630 1];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[0.559 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[0.544 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.623 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73
0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.552 1];[73 0];[75 0];[77 0];[79 0];[81
0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.596 0];[73 0];[75
0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.545 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[0.771 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.589 0];[73 0];[75
0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.558 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[0.532 0]];
%data(4).values = [[0.949 1];[0.864 1];[3 0];[0.376 1];[7.5 0];[10 0];[0.235 1];[13 0];[19
0];[22 0];[16 0];[0.430 1];[28 0];[31 0];[33 0];[34.5 0];[39 0];[0.928 1];[42 0];[43 0];[45
0];[47 0];[49 0];[51 0];[53 0];[0.726 1];[57 0];[59 0];[61 0];[63 0];[65 0];[67 0];[69
0];[0.897 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.630 1];[73 0];[75 0];[77
0];[79 0];[81 0];[83 0];[85 0];[0.559 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85
0];[0.544 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73 0];[75 0];[77 0];[79
0];[81 0];[83 0];[85 0];[0.623 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[73
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0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.552 1];[73 0];[75 0];[77 0];[79 0];[81
0];[83 0];[85 0];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.596 1];[73 0];[75
0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.545 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[0.771 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.589 1];[73 0];[75
0];[77 0];[79 0];[81 0];[83 0];[85 0];[0.558 1];[73 0];[75 0];[77 0];[79 0];[81 0];[83
0];[85 0];[0.532 1]];

tdata = [[0];[1];[2];[4];[5];[7];[9];[10];[12];[14];[15];[17];[20];[24];[27];[30];
[33];[36];[40];[42];[45];[47];[50];[53];[57];[60];[63];[67];[70];[72];[75];[77];[80];[83];[8
7];[90];[93];[97];[100];[102];[105];[108];[110];[113];[117];[119];[120];[125];[130];[135]
;[140];[145];[147];[150];[155];[160];[165];[170];[175];
[180];[185];[190];[195];[200];[205];[210];[215];[220];[225];[230];[235];[240];[245];[25
0];[255];[260];[265];[270];[275];[280];[285];[290];[295];[300];[305];[310];[315];[320];[
323];[327];[329];[330];[335];[340];[343];[347];[350];[355];[360]];
data(1).ppn = 0;
data(1).tdata = tdata .*60+ 2000*60;
%NFkB in the nucleas
data(1).values = [[1 1];[1 0];[1 0];[1 0];[1.47 1];[1 0];[1 0];[6.51 1];[1 0];[1 0];[9.71 1];[1
0];[1 0];[1 0];[1 0];[13.22 1];[1 0];[1 0];[1 0];[1 0];[6.43 1];[1 0];[1 0];[1 0];[1 0];[5.64
1];[1 0];[1 0];[1 0];[1 0];[5.27 1];[1 0];[1 0];[1 0];[1 0];[10.08 1];[1 0];[1 0];[1 0];[1
0];[9.28 0];[1 0];[1 0];[1 0];[1 0];[1 0];[6.95 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[5.67
0];[1 0];[1 0];[1 0];[1 0];[1 0];[7.31 0];[1 0];[1 0];[1 0];[1 0];[1 0];[7.51 0];[1 0];[1 0];[1
0];[1 0];[1 0];[6.88 0];[1 0];[1 0];[1 0];[1 0];[1 0];[6.77 0];[1 0];[1 0];[1 0];[1 0];[1
0];[7.84 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[7.47 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1
0];[8.23 0]];
% total IkBa in the cytoplasm
data(3).ppn = 0;
data(3).tdata = tdata .*60+ 2000*60;
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data(3).values = [[1.0 1];[1 0];[1 1];[1 0];[0.97 1];[1 0];[1 0];[0.57 1];[1 0];[1 0];[0.26
1];[1 0];[1 0];[1 0];[1 0];[0.48 1];[1 0];[1 0];[1 0];[1 0];[0.95 1];[1 0];[1 0];[1 0];[1
0];[0.76 1];[1 0];[1 0];[1 0];[1 0];[0.80 1];[1 0];[1 0];[1 0];[1 0];[0.77 1];[1 0];[1 0];[1
0];[1 0];[0.59 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.58 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1
0];[0.67 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.61 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.73 0];[1
0];[1 0];[1 0];[1 0];[1 0];[0.69 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.85 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.70 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.88 0];[1 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.61 0]];
% total IkBb in the cytoplasm
data(5).ppn = 0;
data(5).tdata = tdata .*60+ 2000*60;
data(5).values = [[0.73 1];[1 0];[0.62 1];[1 0];[0.63 1];[1 0];[1 0];[0.50 1];[1 0];[1
0];[0.38 1];[1 0];[1 0];[1 0];[1 0];[0.27 1];[1 0];[1 0];[1 0];[1 0];[0.27 1];[1 0];[1 0];[1
0];[1 0];[0.23 1];[1 0];[1 0];[1 0];[1 0];[0.20 1];[1 0];[1 0];[1 0];[1 0];[0.22 1];[1 0];[1
0];[1 0];[1 0];[0.43 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.38 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1
0];[0.53 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.49 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.64 0];[1
0];[1 0];[1 0];[1 0];[1 0];[0.63 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.74 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.67 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.86 0];[1 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.70 0]];

%Experiment 2
%NFkB in the nucleaus with DCPA treatment
%
data(2).ppn = 100;
data(2).tdata = tdata.*60+2000*60;
data(2).values = [[1 1];[1 0];[1 0];[1 0];[1.41 1];[1 0];[1 0];[6.60 1];[1 0];[1 0];[11.11
1];[1 0];[1 0];[1 0];[1 0];[10.77 1];[1 0];[1 0];[1 0];[1 0];[6.01 1];[1 0];[1 0];[1 0];[1
0];[6.21 1];[1 0];[1 0];[1 0];[1 0];[7.93 1];[1 0];[1 0];[1 0];[1 0];[9.30 1];[1 0];[1 0];[1
0];[1 0];[7.49 0];[1 0];[1 0];[1 0];[1 0];[1 0];[5.72 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1
0];[5.75 0];[1 0];[1 0];[1 0];[1 0];[1 0];[8.80 0];[1 0];[1 0];[1 0];[1 0];[1 0];[7.60 0];[1
0];[1 0];[1 0];[1 0];[1 0];[6.84 0];[1 0];[1 0];[1 0];[1 0];[1 0];[6.57 0];[1 0];[1 0];[1 0];[1
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0];[1 0];[8.18 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[7.78 0];[1 0];[1 0];[1 0];[1 0];[1
0];[1 0];[9.20 0]];
% total IkBa in the cytoplasm
% total IkBa in the cytoplasm
data(4).ppn = 100;
data(4).tdata = tdata .*60+ 2000*60;
data(4).values = [[1.0 1];[1 0];[0.96 1];[1 0];[0.87 1];[1 0];[1 0];[0.38 1];[1 0];[1 0];[0.25
1];[1 0];[1 0];[1 0];[1 0];[0.44 1];[1 0];[1 0];[1 0];[1 0];[0.93 1];[1 0];[1 0];[1 0];[1
0];[0.73 1];[1 0];[1 0];[1 0];[1 0];[0.90 1];[1 0];[1 0];[1 0];[1 0];[0.64 1];[1 0];[1 0];[1
0];[1 0];[0.57 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.56 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1
0];[0.63 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.57 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.62 0];[1
0];[1 0];[1 0];[1 0];[1 0];[0.55 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.79 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.60 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.58 0];[1 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.55 0]];
% total IkBb in the cytoplasm
% total IkBb in the cytoplasm
data(6).ppn = 0;
data(6).tdata = tdata .*60+ 2000*60;
data(6).values = [[0.73 1];[1 0];[0.56 1];[1 0];[0.54 1];[1 0];[1 0];[0.43 1];[1 0];[1
0];[0.28 1];[1 0];[1 0];[1 0];[1 0];[0.23 1];[1 0];[1 0];[1 0];[1 0];[0.22 1];[1 0];[1 0];[1
0];[1 0];[0.20 1];[1 0];[1 0];[1 0];[1 0];[0.21 1];[1 0];[1 0];[1 0];[1 0];[0.23 1];[1 0];[1
0];[1 0];[1 0];[0.34 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.34 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1
0];[0.43 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.43 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.47 0];[1
0];[1 0];[1 0];[1 0];[1 0];[0.45 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.72 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.65 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[1 0];[0.62 0];[1 0];[1 0];[1 0];[1 0];[1
0];[1 0];[0.63 0]];
return;
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Supplement 3.1 : Gel image for IκBα in the cytoplasm
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Supplement 3.2 : Gel image for β-actin
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Supplement 3.3 : Gel image for IκBβ in the cytoplasm
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Supplement 3.4 : Gel image for Free NFκB in the nucleus
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